<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
   xmlns:ao="http://www.w3.org/ns/oa#"
   xmlns:dailymed="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/"
   xmlns:dct="http://purl.org/dc/terms/"
   xmlns:dikbD2R="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/"
   xmlns:domeo="http://www.w3.org/ns/domeo#"
   xmlns:foafx="http://xmlns.com/foaf/0.1/"
   xmlns:pav="http://purl.org/pav/"
   xmlns:permissions="http://vocab.deri.ie/cpo#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns:sio="http://semanticscience.org/resource/"
>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27">
    <ao:item rdf:resource="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA"/>
    <permissions:permissions rdf:nodeID="N3726534af4fd45c583ba1fd3f0a5be24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C02BE13-5688-4657-A7A7-6A459283AEB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <pav:previousVersion>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D37CC60-618E-46B6-8C99-BA7D598E3762"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBB863B4-0141-4362-8357-0FD5A3909A10"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7907DD5-4FA4-4B5A-99D9-9D24B76931C6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5DE379E-8BB3-4609-BFC6-A0E275978ADC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:10BB95F9-1856-4D70-9976-235CE8AD3D39"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76D782E-ADBF-42D0-9CCA-8944F07D22DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA7B78BE-B91C-4178-9AF1-7DC800EF5121"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C5BA635-EF8B-4165-A2A6-5832D61A15BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55E300CE-2A8F-42F4-9877-A49DDE4F3360"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79293219-D172-4E27-A045-D16B4F539C60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0DCF362-11F8-4FF3-8C3C-EDB9DD3D53A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B85AE85-A07C-4614-91F5-52EF7A4737DF"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6"/>
    <pav:lastSavedOn>2014-07-07 11:36:14 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:74FDA5BD-9C18-4F10-AC59-C5C75AA497C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:57E98049-37B0-4F70-963B-F0D12C3B36C7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:735CA4BD-A16D-4729-BFC3-96D72BFE5B0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D22E6FA-B90D-49C2-B42F-B8122D48D82A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8"/>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/093D1F2A-587E-4B3C-AAF4-10347561D8A9">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sildenafil</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6BF6E19B-3833-4401-A589-B16E9522C485">
    <ao:exact>REVATIO </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>6BF6E19B-3833-4401-A589-B16E9522C485</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Injection: The pharmacokinetic profile of REVATIO has been characterized following intravenous administration. A 10 mg dose of </ao:prefix>
    <pav:createdOn>2014-07-07 09:58:53 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6BF6E19B-3833-4401-A589-B16E9522C485"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>Injection is predicted to provide a pharmacological effect of sildenafil and its N-desmethyl metabolite equivalent to that of a 20 mg oral dose.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B6560EB-DD3A-4FD9-ACE8-690CA260DD8B">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:45DFA268-E20B-41A7-BE0C-703868597D0E</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:15:09 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:76258D2D-1630-4254-82ED-C3434163EAE3"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C15235C1-3B10-4949-B8E4-1D7FCCD3AC4B">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:1230CFBE-6F41-4107-8D50-5F5A730D40C5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:89484DAB-0EA9-4ACB-BC2F-9FEC34383940</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:07:49 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50649F2A-1F77-4AC3-AA05-9C465AAF3D79">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:59:10 -0400</pav:createdOn>
    <domeo:uuid>50649F2A-1F77-4AC3-AA05-9C465AAF3D79</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> pharmacokinetics in patients with PAH.</ao:suffix>
    <ao:prefix> in patients with PAH. The dataset available for the population pharmacokinetic evaluation contained a wide range of demographic data and laboratory parameters associated with hepatic and renal function. None of these factors had a significant impact on </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:50649F2A-1F77-4AC3-AA05-9C465AAF3D79"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097">
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D4374CEB-BF68-487B-B5EE-5AF06DB14203"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:584394EB-71B4-485C-B5DE-CECED70A1339"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EE5A4249-D765-40E0-B39A-F0725082F558"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3C500E90-E946-4B1B-B3D2-27B11967A625"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7FFFFE5E-7DBF-4B33-A8EC-B5E58DEE590D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4B5E4470-CD28-4DCB-9009-8377503D5E57"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N44d414c01129400d94b75e139631d034"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AE1A087B-7CF8-4549-978E-17FEC965A2FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5736B17-7DDF-4532-8056-6627EB5A439A"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E8BEB68-80C9-4767-BEC0-5810B8C956C0">
    <ao:prefix>Injection is predicted to provide a pharmacological effect of sildenafil and its N-</ao:prefix>
    <pav:createdOn>2014-07-07 09:58:55 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7E8BEB68-80C9-4767-BEC0-5810B8C956C0"/>
    <domeo:uuid>7E8BEB68-80C9-4767-BEC0-5810B8C956C0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>metabolite equivalent to that of a 20 mg oral dose.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>desmethyl </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8232EB8B-B7ED-4583-BE33-F0AD71DA4D1C">
    <ao:exact>Sildenafil </ao:exact>
    <domeo:uuid>8232EB8B-B7ED-4583-BE33-F0AD71DA4D1C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>terases (10-fold for PDE6, &gt; 80-fold for PDE1, &gt; 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5 versus PDE3 is important because PDE3 is involved in control of cardiac contractility. </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 09:36:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8232EB8B-B7ED-4583-BE33-F0AD71DA4D1C"/>
    <ao:suffix>is only about 10-fold as potent for PDE5 compared to PDE6, an enzyme found in the retina and involved in the phototransduction pathway of the retina. This lower selectivity is thought to be the basis for abnormalities related to color vision observed wit</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A">
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:D39EF779-DAF5-4F97-868F-87A730F44650</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:5672F5D0-071A-4DE9-9A98-BD20431A00C2"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6">
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76D782E-ADBF-42D0-9CCA-8944F07D22DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <pav:previousVersion>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:79293219-D172-4E27-A045-D16B4F539C60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B85AE85-A07C-4614-91F5-52EF7A4737DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5DE379E-8BB3-4609-BFC6-A0E275978ADC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7907DD5-4FA4-4B5A-99D9-9D24B76931C6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:74FDA5BD-9C18-4F10-AC59-C5C75AA497C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:57E98049-37B0-4F70-963B-F0D12C3B36C7"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C02BE13-5688-4657-A7A7-6A459283AEB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0DCF362-11F8-4FF3-8C3C-EDB9DD3D53A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55E300CE-2A8F-42F4-9877-A49DDE4F3360"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D22E6FA-B90D-49C2-B42F-B8122D48D82A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:735CA4BD-A16D-4729-BFC3-96D72BFE5B0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBB863B4-0141-4362-8357-0FD5A3909A10"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6"/>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N167cd30c82bb481c9f33961fa16ce5a6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D37CC60-618E-46B6-8C99-BA7D598E3762"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA7B78BE-B91C-4178-9AF1-7DC800EF5121"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D22E6FA-B90D-49C2-B42F-B8122D48D82A">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 11:22:45 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:62F3C932-C305-4581-AA4E-BB34C6D0F7D4"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:462DD4AC-A4D5-481B-AE25-173C924C4620</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA">
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C02BE13-5688-4657-A7A7-6A459283AEB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:735CA4BD-A16D-4729-BFC3-96D72BFE5B0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D37CC60-618E-46B6-8C99-BA7D598E3762"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D22E6FA-B90D-49C2-B42F-B8122D48D82A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA7B78BE-B91C-4178-9AF1-7DC800EF5121"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76D782E-ADBF-42D0-9CCA-8944F07D22DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <permissions:permissions rdf:nodeID="N9f3a4e17e09b48f1b0922df27a510bef"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5DE379E-8BB3-4609-BFC6-A0E275978ADC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C5BA635-EF8B-4165-A2A6-5832D61A15BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79293219-D172-4E27-A045-D16B4F539C60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBB863B4-0141-4362-8357-0FD5A3909A10"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7907DD5-4FA4-4B5A-99D9-9D24B76931C6"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-07 11:37:25 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:10BB95F9-1856-4D70-9976-235CE8AD3D39"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B85AE85-A07C-4614-91F5-52EF7A4737DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0DCF362-11F8-4FF3-8C3C-EDB9DD3D53A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55E300CE-2A8F-42F4-9877-A49DDE4F3360"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:57E98049-37B0-4F70-963B-F0D12C3B36C7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E010F58-AD7C-435C-B2DC-0F81F34B978E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:74FDA5BD-9C18-4F10-AC59-C5C75AA497C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA"/>
    <pav:previousVersion>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B06BD29E-2481-4EA0-885B-420749EBE703">
    <ao:exact>fluconazole</ao:exact>
    <ao:prefix>, there was a significant decrease in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:46:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B06BD29E-2481-4EA0-885B-420749EBE703"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from o</ao:suffix>
    <domeo:uuid>B06BD29E-2481-4EA0-885B-420749EBE703</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6887274E-F614-42FD-904F-B7E202949297">
    <ao:prefix> is 90%, and that of its major metabolite, </ao:prefix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>6887274E-F614-42FD-904F-B7E202949297</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in th</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6887274E-F614-42FD-904F-B7E202949297"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:11:10 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3">
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7"/>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="Nad3798ec80d04bc6967c5c08004882ab"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BAE41BF7-CAA3-4865-832D-24EB9699E14C">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdfs:label>erythromycin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4374CEB-BF68-487B-B5EE-5AF06DB14203">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:455774FE-0093-4F4D-84D8-16C42C340D54</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:42:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8380B817-2385-42D1-ACFB-89134B65210A"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:630D3E24-BEE4-405B-B4BF-F8D5BE2929A7</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:EAE26632-A8D8-4E80-ADE1-8902853460F6"/>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:39:26 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D526C276-CAAE-4E9B-8038-08BB2FB8FBBD">
    <domeo:uuid>D526C276-CAAE-4E9B-8038-08BB2FB8FBBD</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, and </ao:prefix>
    <ao:exact>phenobarbital</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D526C276-CAAE-4E9B-8038-08BB2FB8FBBD"/>
    <pav:createdOn>2014-07-13 11:15:55 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D909BDC5-468E-434E-B3E5-632F1565E73C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D909BDC5-468E-434E-B3E5-632F1565E73C"/>
    <ao:suffix> (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <ao:prefix> displaces each other from plasma binding sites. High therapeutic concentrations of s</ao:prefix>
    <ao:exact>ulfamethazine</ao:exact>
    <pav:createdOn>2014-07-13 11:11:25 -0400</pav:createdOn>
    <domeo:uuid>D909BDC5-468E-434E-B3E5-632F1565E73C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC34C3D8-C58F-483B-80DB-B65FEBB2EC20">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>DC34C3D8-C58F-483B-80DB-B65FEBB2EC20</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>is cleared predominantly by the CYP3A (major route) and cytochrome P450 2C9 (CYP2C9, minor route) hepatic microsomal isoenzymes. The major circulating metabolite results from N-desmethylation of sildenafil, and is, itself, further metabolized. This metab</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:42:51 -0400</pav:createdOn>
    <ao:exact>Sildenafil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC34C3D8-C58F-483B-80DB-B65FEBB2EC20"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF">
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:39:24 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:AEC296E5-554D-42F1-BF6A-CA09B038958F"/>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:70ECE601-93F6-46C3-A2D3-93CE5E029677</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA5EEC38-13CE-4D77-8996-A3CFF229A32F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:34:23 -0400</pav:createdOn>
    <domeo:uuid>AA5EEC38-13CE-4D77-8996-A3CFF229A32F</domeo:uuid>
    <ao:exact>-</ao:exact>
    <ao:suffix>5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hyperte</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AA5EEC38-13CE-4D77-8996-A3CFF229A32F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA8337B7-4497-4F34-93E8-291B9ED278CB">
    <ao:context rdf:resource="urn:domeoclient:uuid:8214D15C-5AF1-47D0-A63C-30543353403D"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 12:37:44 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:6D41F524-FA45-4B72-94A7-36317513638D</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:40:26 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B5AC23C4-D57A-4FA8-9939-152CD7533DC3</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3D2E5F5D-2D44-4EC9-93CD-D558EE6CAD75"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1C706B9-7F27-4C22-8F0D-E46B96B35A86">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C1C706B9-7F27-4C22-8F0D-E46B96B35A86</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:exact>fluconazole</ao:exact>
    <ao:prefix> AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of </ao:prefix>
    <pav:createdOn>2014-07-13 12:56:11 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C1C706B9-7F27-4C22-8F0D-E46B96B35A86"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF">
    <pav:lineageUri>urn:domeoserver:annotation:187E096B-963B-4ED9-97FB-5E69A71AD4B3</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E766D1AC-45BC-4579-89AD-BE0DEC69FC35"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-07 09:42:25 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406">
    <ao:item rdf:resource="urn:domeoclient:uuid:3B85AE85-A07C-4614-91F5-52EF7A4737DF"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B1CD5D-3CD7-4D5E-BD76-57F6F0A9480A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0DCF362-11F8-4FF3-8C3C-EDB9DD3D53A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55E300CE-2A8F-42F4-9877-A49DDE4F3360"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D37CC60-618E-46B6-8C99-BA7D598E3762"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA7B78BE-B91C-4178-9AF1-7DC800EF5121"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5DE379E-8BB3-4609-BFC6-A0E275978ADC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76D782E-ADBF-42D0-9CCA-8944F07D22DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C5BA635-EF8B-4165-A2A6-5832D61A15BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:735CA4BD-A16D-4729-BFC3-96D72BFE5B0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBB863B4-0141-4362-8357-0FD5A3909A10"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7907DD5-4FA4-4B5A-99D9-9D24B76931C6"/>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA"/>
    <pav:previousVersion>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD9047F-C1DA-4B64-92B7-4D031972C9CF"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C02BE13-5688-4657-A7A7-6A459283AEB2"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F71B86E-3B80-4813-9F00-A9E3E6B30C9E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D22E6FA-B90D-49C2-B42F-B8122D48D82A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA"/>
    <permissions:permissions rdf:nodeID="Neb5627b9feaf4d479103a379d17a0fb7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB0C633B-9063-4FD0-91E9-2810CF1C157A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79293219-D172-4E27-A045-D16B4F539C60"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:74FDA5BD-9C18-4F10-AC59-C5C75AA497C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:57E98049-37B0-4F70-963B-F0D12C3B36C7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093FF56-689E-4246-AF69-F566860B27BF"/>
    <pav:lastSavedOn>2014-07-07 11:35:31 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C6FF426-D0F6-4DFE-8C13-8BD0EAA98C6F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0C6FF426-D0F6-4DFE-8C13-8BD0EAA98C6F</domeo:uuid>
    <pav:createdOn>2014-07-13 12:46:15 -0400</pav:createdOn>
    <ao:suffix> 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0C6FF426-D0F6-4DFE-8C13-8BD0EAA98C6F"/>
    <ao:prefix> 100 mg was administered as a single oral dose alone and two hours after a single dose of </ao:prefix>
    <ao:exact>cimetidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E6A5356C-B181-4F61-AEF2-74464A340D7F">
    <ao:context rdf:resource="urn:domeoclient:uuid:5FBE9544-4653-482C-B065-70CA3AA07309"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C5FD329C-F801-4589-8147-439BFA776D12</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:15:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D346F3FB-2896-495E-BF67-B2BC6E8F5714">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:41:30 -0400</pav:createdOn>
    <ao:suffix>is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%). Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When REVATIO is taken</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>D346F3FB-2896-495E-BF67-B2BC6E8F5714</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D346F3FB-2896-495E-BF67-B2BC6E8F5714"/>
    <ao:exact>REVATIO </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8D94772-B85A-452F-91A5-C644F8298C08">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7E8BEB68-80C9-4767-BEC0-5810B8C956C0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:58:55 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:34C83714-44E7-4047-8688-163A67040E44</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:420A77EC-3CAE-4EA3-B428-B635FA4A9F5D">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:11:13 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:1734C6CD-F7E3-40D2-B440-4C5D8B428556</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:804C4BF7-B45B-4CC2-BD44-707AAD50F219"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC861D6D-4076-4F69-B134-B404C685F91A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> was decreased, and elimination half-lives were prolonged compared to young healthy subjects. Dosing should be modified accordingly in the elderly patients [see 2 DOSAGE AND ADMINISTRATION].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:18:24 -0400</pav:createdOn>
    <domeo:uuid>CC861D6D-4076-4F69-B134-B404C685F91A</domeo:uuid>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC861D6D-4076-4F69-B134-B404C685F91A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232">
    <ao:item rdf:resource="urn:domeoclient:uuid:23E5F3F5-E089-460E-A736-58E2FC44ADC6"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C4061A3-979D-486B-9CDA-1CFF771CCB5B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6ECE2E9A-54C4-4507-95A6-2F4053719529"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EC654F2-7C5C-4C0B-9973-518245983B18"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B088F7FA-8870-4336-965B-4A558E3F08B0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:420A77EC-3CAE-4EA3-B428-B635FA4A9F5D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:651C0626-4BF6-4B96-A66A-7385C6456D51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8E221E79-602A-4812-8488-538D6506C879"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CAC294B3-5790-4488-B65C-CB3269F765C6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7AF3A49F-90C3-4D03-97CB-74AE03BF7C86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95AEC430-A2F4-4B0D-B623-70050D7B891E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:97FF727B-70F7-4A8F-9355-6D53C2602A7E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34472B29-EA4E-45E5-84B2-2EEE556610B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71E5047C-5690-4D45-9A6E-FB1384C14928"/>
    <pav:lineageUri>urn:domeoserver:annotationset:90C0A4CD-5288-4960-B31A-195D0159FE45</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:017A9836-D985-4347-BFF0-9EBED8DB5CD1"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:56F428F6-CAF7-4343-B57C-103B1BA935EB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8EAC93E7-05D8-439B-86B4-7B47CB07E8D8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DFCBEAF2-DEEA-4C46-A167-B2B6F5C56C00"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E202AAE6-7DCA-486D-9C29-8CB3B82CFECF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5FF2B43E-5E15-4C21-BFDD-C97D4C18B3B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C5594C9A-8B88-4CF6-B5AA-3F081580D92D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9F3CA373-B79A-4B2D-8C96-BFB67CB4B175"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBE541BF-AED9-48E5-ACA0-9309C45B20F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:64792593-BEAB-4B65-88FB-A2254663F469"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A6F0B480-ABD4-436B-8A6F-A4BD34827F73"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:464ED203-77EC-4EFC-873A-7853A308DCA5"/>
    <pav:createdOn>2014-07-13 11:04:07 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:5BA6BC8B-1F30-4288-9D03-060F552BAA12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9AF0B949-C133-4703-9F65-362D4B5B4494"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F46BEE2C-B82E-4386-96D7-C74221898C04"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0AC105E-C659-4D3F-9F13-4104BCC29CDE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE717566-90D0-4B59-B00F-B053CAE639C4"/>
    <permissions:permissions rdf:nodeID="Nb1684bf5377b45158d6824adb5dc9100"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9011E52E-6FAE-42BF-913B-D3EF952E8A2B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:97C1D6A3-E462-4C1F-8DD6-513D5AD2268A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2EC8E075-F7E3-4259-A656-99D292E9F0A4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E73E8FF7-7FA2-47F3-B0B1-14D1640DDBF7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90F5AA7B-F35E-4B00-A666-C6FE8F1B0324"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0025BED1-B4CA-4D8F-9C43-B2F10841CCF4"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B743E18-8323-4761-B0A4-3B200C16F9BE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:99E97745-423E-4818-BFC6-3F67C8BF2A87"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:92436D94-1FB4-49B2-B20D-385CA961A940"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFBA3663-4C52-45BA-895B-7EB3C0A4DA3A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8B475492-95FE-4CDD-81AE-94DFEEB91E11"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5F8E4E79-C59A-410E-ACD6-41B9C532F968"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9C5564E-F653-404D-B333-299E63141AF5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A361190A-A611-4162-AA47-4014AAEBA0B2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6B6560EB-DD3A-4FD9-ACE8-690CA260DD8B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:92DB5361-BE2B-4C69-B141-FB431E8EFC22"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:454E7688-A4B1-42BF-86B5-6E1A3C88986A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA2C0A64-143A-46D5-A408-01FC3EC62525"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FD9D4BD5-A390-4CD6-8FF4-21ABE76D596A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14556CC1-0C55-47A6-8175-973C292639CC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:518CD4C6-1719-48AB-B300-84A10DEACB68"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:72843AE3-90CC-43FD-BCEC-E83B4E3A7EDF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A93D3C-935C-417F-BE1B-282EDBEB8D85"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5B622988-60A1-49F1-966B-8460BBF1DD4D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:05BFBD66-D24D-4F61-89C5-4EDDE7B6040C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E6A5356C-B181-4F61-AEF2-74464A340D7F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:420B9B73-0394-4975-8634-61202EA8F217"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04EFF21D-F5C9-468D-BFA5-057DD08ABD00"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C446162-FA92-4715-9095-A116DC12F4C8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2532730F-81C6-4CC5-93B2-FC3A19B98EC5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA230F0A-406C-43AE-88DE-A7FD67CF4D61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4019A76A-1D16-4F04-8CBF-FF855DD2A7A2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1E597BBC-9857-4D08-953B-5CBE831F5884"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:72584FCC-E5F1-4130-993B-ED469AE3E810"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2537CEFB-4053-4AC9-8731-C65B1AC5D0F9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6DDA4ED5-743F-4C12-93A8-37B2366FF364"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A46A827E-4936-4BBC-8078-913DD6DAA84E"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD1E279-39ED-4853-AF2E-BE56BEB4AF03"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CC41192-004E-44F9-8E3D-0FF7CECF1DC2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E728D92E-FEA6-4EE6-9E40-E59051DEB8E3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E8680340-7715-4656-A160-A6F608AD7CE9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EEC761C8-1050-4E1A-A450-D460F8514160"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:539264FC-F626-408A-BB71-03BC387083CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0D7139F9-BDC3-437F-A5A1-D75EDAC972B0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B18CF78-48CD-4D32-B4F4-88F8072C8185"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3805F006-2423-4B51-87AB-CAE85C6B4E21"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4E77E45D-0BB8-4168-8CAF-9D1591E37A36"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C15235C1-3B10-4949-B8E4-1D7FCCD3AC4B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F94384BA-7A08-4E0D-A89C-A73959BAA203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:89155DC0-3493-4590-8DD7-44717F141C27"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:934B866B-AFCB-4F4A-A5CA-1B312B3088E1"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:94239CD6-2883-459B-A125-FF55B9791833"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A151EB77-7400-49F2-9673-BFAD2171D5CD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D04CBBE-379A-4D9F-BDD4-AA3663CD4669">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 11:36:13 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>2D04CBBE-379A-4D9F-BDD4-AA3663CD4669</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Cimetidine (800 mg), a nonspecific CYP inhibitor, caused a 56% increase in plasma sildenafil concentrations when co-administered with sildenafil (50 mg) to healthy volunteers</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2D04CBBE-379A-4D9F-BDD4-AA3663CD4669"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3BEBBBC1-7503-4FA0-9B16-ED708F2AE108">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 12:38:53 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:2A576179-7248-4360-B213-E95632A0489F</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:371BCC12-3242-4854-9882-2DB2B2EE1A70"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeo:software:id:Domeo-2.1alpha-050">
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Software"/>
    <foafx:name>Domeo Annotation Toolkit</foafx:name>
    <rdfs:label>Domeo Annotation Toolkit</rdfs:label>
    <foafx:build>050</foafx:build>
    <foafx:version>2.1alpha</foafx:version>
    <foafx:homepage></foafx:homepage>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A412DBFC-2FE0-43FA-A538-B84D822A5BFD">
    <ao:suffix>pharmacologic effects. In patients with pulmonary arterial hypertension, however, the ratio of the metabolite to sildenafil is higher. Both sildenafil and the active metabolite have terminal half-lives of about 4 hours.</ao:suffix>
    <ao:exact>sildenafil's </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>A412DBFC-2FE0-43FA-A538-B84D822A5BFD</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A412DBFC-2FE0-43FA-A538-B84D822A5BFD"/>
    <ao:prefix>, so that the metabolite accounts for about 20% of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 09:44:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F8E4E79-C59A-410E-ACD6-41B9C532F968">
    <pav:lineageUri>urn:domeoserver:annotation:FDE2CC52-F5FC-4C63-AEAD-C53C36960021</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 11:14:57 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:806597EC-5BAB-46E0-96D6-B25563A80A8C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7C1B3FD3-CA8D-4D2F-B094-F0DB74BF2108">
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:390CA5FE-7939-4F69-B612-7F5C21A06481">
    <domeo:belongsToSet>urn:domeoclient:uuid:71CADA90-E1E5-4B50-9394-FDFC0B1512B0</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:02:05 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1085914C-2530-49EB-92B4-1E4BC17AEBAC"/>
    <pav:lastSavedOn>2014-07-13 11:02:34 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:9CBDBE67-2211-4254-BEF8-DDC84C5BB035</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1F12731E-6D41-4E27-83E3-C87822424FCA">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:35639159-ED9C-4B53-8BA3-5D1C355CF374</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:59:05 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F14E8BB4-85EC-49A7-B9E5-8976B448D19D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30903A1B-437C-4ABA-B24D-6148F07F178D">
    <ao:suffix> plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour. Peak conce</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30903A1B-437C-4ABA-B24D-6148F07F178D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:09:35 -0400</pav:createdOn>
    <ao:prefix>, its major metabolite, 9-hydroxyrisperidone, and </ao:prefix>
    <domeo:uuid>30903A1B-437C-4ABA-B24D-6148F07F178D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF3DBDD7-1816-4E91-BF27-7D21BEF67A06">
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>CF3DBDD7-1816-4E91-BF27-7D21BEF67A06</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 11:37:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CF3DBDD7-1816-4E91-BF27-7D21BEF67A06"/>
    <ao:exact>In a study performed in healthy volunteers, co-administration of the HIV protease inhibitor saquinavir, a CYP3A inhibitor, at steady state (1200 mg TID) with sildenafil (100 mg single dose) resulted in a 140% increase in sildenafil Cmax and a 210% increase in sildenafil AUC</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17E64297-0A57-4C9B-94C4-18ED1956FCF7">
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:2F1405B4-F41E-4809-AC54-DA4B296E83DB</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:51:17 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7950DCED-7411-4B59-B629-CB1341A53897"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04EFF21D-F5C9-468D-BFA5-057DD08ABD00">
    <pav:createdOn>2014-07-13 11:11:36 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E804A110-85A5-4650-B960-F11AB9FD25A2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:9901869B-6CBE-4242-B8B1-1CE8B5D728FA</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:489FB94C-2475-4EC7-BE20-CF92749745A7">
    <ao:context rdf:resource="urn:domeoclient:uuid:B0AC894E-27E2-43D9-BFEB-167E8117247A"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 12:34:38 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:88C1F1C9-E75C-4A69-9BFF-84FAF6F2C2ED</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 12:34:42 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:6A05795B-B1AB-4DB3-A12F-2765CBCC2FED</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A1E742B-4ABE-40BF-84E5-2A5F57F232F2">
    <ao:prefix> is well absorbed. The absolute oral bioavailability of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0A1E742B-4ABE-40BF-84E5-2A5F57F232F2"/>
    <pav:createdOn>2014-07-13 11:09:15 -0400</pav:createdOn>
    <domeo:uuid>0A1E742B-4ABE-40BF-84E5-2A5F57F232F2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:222C9B55-A770-41C7-AF04-566E7C7A1DBC">
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:43:42 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B9D56D7C-5C37-4BCA-B9C4-0605E9E54998"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:0B532474-916D-40A3-BDAD-D06FF3A01947</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4ADFA01-70C2-42CC-87CC-869B81E3104E">
    <pav:createdOn>2014-07-13 12:46:24 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6A0AE7AB-260B-4296-BC83-DB443FEE5161"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:56FD27A9-9A20-480B-9750-E65B79E50EDB</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F230A2C-E15E-41D9-8781-4AF5CA3E381E">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:C0DCB0F4-61CC-48CE-8688-567F2327B321"/>
    <pav:createdOn>2014-07-13 12:46:27 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:6DC77E85-D03E-4E33-9B0F-4B8826F63FA7</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C29885C9-C34F-446F-88D0-5C6DE9D91033">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>s metabolite has a phosphodiesterase selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% of the parent drug. In healthy volunteers, plasma concentrations of this metabolite are approximately 40% of those seen for </ao:prefix>
    <ao:suffix>, so that the metabolite accounts for about 20% of sildenafil's pharmacologic effects. In patients with pulmonary arterial hypertension, however, the ratio of the metabolite to sildenafil is higher. Both sildenafil and the active metabolite have terminal</ao:suffix>
    <pav:createdOn>2014-07-07 09:43:59 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil</ao:exact>
    <domeo:uuid>C29885C9-C34F-446F-88D0-5C6DE9D91033</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C29885C9-C34F-446F-88D0-5C6DE9D91033"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0025BED1-B4CA-4D8F-9C43-B2F10841CCF4">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:15:56 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:0A047BE5-CEF6-494B-A811-C7F89C6D2A1B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F6864EB3-C97B-4F46-976B-E976F8C03348"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0569E8E5-928F-4D8D-93AE-056F350503EF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:FC7F51C8-D140-4695-B609-DCDA64270F6D</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:46:15 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:0C6FF426-D0F6-4DFE-8C13-8BD0EAA98C6F"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FAD17173-A1D3-4A24-A29E-5999F0DFA8F4">
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>Injection: The pharmacokinetic profile of REVATIO has been characterized following intravenous administration. A 10 mg dose of REVATIO Injection is predicted to provide a pharmacological effect of sildenafil and its N-desmethyl metabolite equivalent to t</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>FAD17173-A1D3-4A24-A29E-5999F0DFA8F4</domeo:uuid>
    <ao:exact>REVATIO </ao:exact>
    <pav:createdOn>2014-07-07 09:58:43 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FAD17173-A1D3-4A24-A29E-5999F0DFA8F4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611">
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB66F52A-826A-4B19-9DAB-4F305456531E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:37727E88-1331-4D52-A885-1D4C9745A521</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2F70BCB-D9EC-44EA-93E7-C33A22842BF2"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F4C5D67-B302-4D5E-86D3-E308EE0C607E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1B6D964C-5C7B-4A8B-91D1-71E48BED6297"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE4A37C3-330E-406A-8B07-E596729011D4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:190DDFDA-8456-4B27-972C-5E815FA29EBD"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B4ADFA01-70C2-42CC-87CC-869B81E3104E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 12:46:12 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:5F230A2C-E15E-41D9-8781-4AF5CA3E381E"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="Nfaf4dffc8e564e0baefb87b715f8f7a8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60E67B22-5DBF-4F42-9120-BC7E0F398FA0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0569E8E5-928F-4D8D-93AE-056F350503EF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67CFE2D6-F2AA-4465-A433-B26BEA64FB5E">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:2B2D2409-EC63-45B4-9720-BB70CEBD3CE2</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:42:01 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C5023B49-22AF-4880-9F9A-B1FCB16EAE71"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECB23C3B-E835-480F-B541-EB5CBBAB2855">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:prefix> 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of </ao:prefix>
    <pav:createdOn>2014-07-13 12:46:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ECB23C3B-E835-480F-B541-EB5CBBAB2855"/>
    <ao:suffix> 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:suffix>
    <domeo:uuid>ECB23C3B-E835-480F-B541-EB5CBBAB2855</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fluconazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6FD9D48D-F639-4F09-ABA6-F4B259681453">
    <pav:createdOn>2014-07-07 09:59:10 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:50649F2A-1F77-4AC3-AA05-9C465AAF3D79"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:BCAC0F86-EF1B-48A6-B71C-46750D478032</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9E21C61-063D-4F80-8E08-85865B387669">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:7BCC1444-4E3C-4804-B95F-68D13D651A9A</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8232EB8B-B7ED-4583-BE33-F0AD71DA4D1C"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:36:49 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C5BA635-EF8B-4165-A2A6-5832D61A15BF">
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:35:32 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="Nb3430e02bd5144f98224ed9fcabd8669"/>
    <ao:body rdf:nodeID="N560bf5816a5d4547a5773f7a25fb99b9"/>
    <pav:createdOn>2014-07-07 11:35:30 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F97F910-5C88-42D5-BF36-6EFC8C9A3DD1"/>
    <ao:body rdf:nodeID="N1593c06e90314edea19be995cd63ccee"/>
    <pav:lineageUri>urn:domeoserver:annotation:9EA45124-7E00-46A6-9CA4-F4521FB8A397</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-07 11:35:31 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8EA1563F-47E7-4983-918E-643A5D2021DC">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>8EA1563F-47E7-4983-918E-643A5D2021DC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>on Vision</ao:suffix>
    <ao:prefix>Effects of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8EA1563F-47E7-4983-918E-643A5D2021DC"/>
    <pav:createdOn>2014-07-07 09:40:48 -0400</pav:createdOn>
    <ao:exact>REVATIO </ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8ABD9FDA-0F08-474A-A9C8-437A5346F2AC">
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:40:23 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:880929CF-0105-4579-A800-E42B40197857</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:20B4F69C-E14E-46A0-8FCE-6AAC4D5EF0B0"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E010F58-AD7C-435C-B2DC-0F81F34B978E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:37:21 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:37:25 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:6AED9017-2775-4A23-915C-FCB7842E4D54</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:CF3DBDD7-1816-4E91-BF27-7D21BEF67A06"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nce581b8f5faf488590b098cd49a7605c"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2AC08E4-8A5F-4E68-B2F1-20AFB690BAC7">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>clearance when it was co-administered with CYP3A inhibitors. </ao:prefix>
    <pav:createdOn>2014-07-07 11:22:40 -0400</pav:createdOn>
    <ao:exact>Sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E2AC08E4-8A5F-4E68-B2F1-20AFB690BAC7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>exposure without concomitant medication is shown to be 5-fold higher at a dose of 80 mg TID compared to its exposure at a dose of 20 mg TID. This concentration range covers the same increased sildenafil exposure observed in specifically-designed drug int</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E2AC08E4-8A5F-4E68-B2F1-20AFB690BAC7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFCBEAF2-DEEA-4C46-A167-B2B6F5C56C00">
    <pav:lineageUri>urn:domeoserver:annotation:AB8C215A-FA3F-4A34-A334-0F1287CE0DA8</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 11:09:11 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:49F82F74-6EDD-4994-8052-10CB1FCA4BA0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6588D45E-2F4C-40CF-8AF4-0CD621F484E1">
    <pav:lineageUri>urn:domeoserver:annotation:905A65BE-2FB4-442E-92C6-EA5747341AA6</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:FAD17173-A1D3-4A24-A29E-5999F0DFA8F4"/>
    <pav:createdOn>2014-07-07 09:58:43 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:612855C1-32AF-48C7-A341-A649DD897808">
    <pav:createdOn>2014-07-13 11:16:05 -0400</pav:createdOn>
    <domeo:uuid>612855C1-32AF-48C7-A341-A649DD897808</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:612855C1-32AF-48C7-A341-A649DD897808"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and </ao:prefix>
    <ao:suffix> [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:804C4BF7-B45B-4CC2-BD44-707AAD50F219">
    <pav:createdOn>2014-07-13 11:11:13 -0400</pav:createdOn>
    <domeo:uuid>804C4BF7-B45B-4CC2-BD44-707AAD50F219</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone</ao:exact>
    <ao:prefix>, is 77%. Neither </ao:prefix>
    <ao:suffix> nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidon</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:804C4BF7-B45B-4CC2-BD44-707AAD50F219"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FC76D7A1-BCF3-4AF0-92CC-E5D2F09F6BD7">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7FE9AC63-C53E-4EF9-AEF0-CC1F82EDA7C3"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E5D76E00-F5D9-4E93-B3B6-47859812ACDF">
    <ao:prefix>After chronic dosing of 80 mg </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E5D76E00-F5D9-4E93-B3B6-47859812ACDF"/>
    <pav:createdOn>2014-07-07 09:39:36 -0400</pav:createdOn>
    <ao:suffix>ildenafil</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>TID s</ao:exact>
    <domeo:uuid>E5D76E00-F5D9-4E93-B3B6-47859812ACDF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:137A1951-AA86-4074-9581-B011801B955F">
    <ao:context rdf:resource="urn:domeoclient:uuid:5FD113AB-8FB6-4F29-B1BE-0A776992E0B0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:00BCB920-F72B-4D37-B5EA-82E77099F0EE</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:39:42 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0F812BF-119E-4BE1-AAA3-BF2DAE39B76F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix>Studies in vitro have shown that </ao:prefix>
    <ao:suffix>is selective for PDE5. Its effect is more potent on PDE5 than on other known phosphodiesterases (10-fold for PDE6, &gt; 80-fold for PDE1, &gt; 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:36:31 -0400</pav:createdOn>
    <domeo:uuid>C0F812BF-119E-4BE1-AAA3-BF2DAE39B76F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C0F812BF-119E-4BE1-AAA3-BF2DAE39B76F"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB4AA59B-BD34-4506-A617-157D639949C4">
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 12:44:29 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:EBDA4EF3-E793-47E4-9F6F-74592DE48307"/>
    <pav:lineageUri>urn:domeoserver:annotation:12FF752F-ABCD-4F14-B2B9-41A0476FEF33</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A29DA787-54E3-4422-B166-2BA6676BC91D">
    <ao:prefix> at 10 ng/mL and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:11:50 -0400</pav:createdOn>
    <ao:suffix> at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>A29DA787-54E3-4422-B166-2BA6676BC91D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A29DA787-54E3-4422-B166-2BA6676BC91D"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1FCFC8E7-95A0-4188-9582-891391C2CFE6">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7AF3A49F-90C3-4D03-97CB-74AE03BF7C86">
    <pav:lineageUri>urn:domeoserver:annotation:0C24008F-78E2-49EE-9161-71EEB60D2ECD</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:09:17 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F557214F-193F-480C-8483-C59A8CFCD22E"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B49DFB13-7D38-41A6-989C-F0F22BFBCA7D">
    <domeo:uuid>B49DFB13-7D38-41A6-989C-F0F22BFBCA7D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:15:18 -0400</pav:createdOn>
    <ao:suffix> do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma c</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B49DFB13-7D38-41A6-989C-F0F22BFBCA7D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given </ao:prefix>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F4C5D67-B302-4D5E-86D3-E308EE0C607E">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:044837BF-E4FA-4C9D-8EA0-E23B27E2EC72</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B06BD29E-2481-4EA0-885B-420749EBE703"/>
    <pav:createdOn>2014-07-13 12:46:20 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3F94F7A-3299-4ECD-8A0C-54D9B0E17A6D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:13:30 -0400</pav:createdOn>
    <ao:prefix> rapidly into </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>F3F94F7A-3299-4ECD-8A0C-54D9B0E17A6D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3F94F7A-3299-4ECD-8A0C-54D9B0E17A6D"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone co</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC8C2FEA-C8BE-4A4F-98E3-3E4C44B65C83">
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>CC8C2FEA-C8BE-4A4F-98E3-3E4C44B65C83</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:14:00 -0400</pav:createdOn>
    <ao:suffix> to 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients </ao:suffix>
    <ao:prefix> could be subject to two kinds of drug-drug interactions. First, inhibitors of CYP 2D6 interfere with conversion of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC8C2FEA-C8BE-4A4F-98E3-3E4C44B65C83"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8ED4F58C-10A8-4F3A-8776-FD6D08A25610">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>8ED4F58C-10A8-4F3A-8776-FD6D08A25610</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), an</ao:suffix>
    <ao:prefix> and α1-acid glycoprotein. The plasma protein binding of </ao:prefix>
    <pav:createdOn>2014-07-13 11:11:00 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8ED4F58C-10A8-4F3A-8776-FD6D08A25610"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/58FED583-F7D0-4B0E-913A-6142C90539F0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9B027AFC-3BAE-4FDC-889F-813F2AD35C5A">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D318A30A-F708-43F6-AB5B-A9D659E063BF"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A7AE105-ADC2-416B-AD5B-0B0B1DB2A2E2">
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:prefix> decreased very slightly (&lt;5%) in 3 of the 21 subjects after </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 12:38:56 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A7AE105-ADC2-416B-AD5B-0B0B1DB2A2E2"/>
    <domeo:uuid>8A7AE105-ADC2-416B-AD5B-0B0B1DB2A2E2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> treatment.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:125C14DB-1F35-4667-846F-F789D6D0AFCF">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E72D7D03-AAE5-42A5-A83A-3C68C2C2BCB6"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:043FCC7B-7CBD-4BE5-9962-3F6CF2B132DB">
    <ao:suffix> oral solution is bioequivalent to risperidone tablets.</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:043FCC7B-7CBD-4BE5-9962-3F6CF2B132DB"/>
    <ao:prefix>Pharmacokinetic studies showed that </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>043FCC7B-7CBD-4BE5-9962-3F6CF2B132DB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:09:21 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42423629-C409-4AD4-BBE6-7C86A696F03E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:createdOn>2014-07-07 09:41:41 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:219B0F32-F586-4381-AC89-B73DA847B68D</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6791DC23-BC40-4E62-815B-0DA5CCA7BD4F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A03AB529-B51D-495B-88D7-404C443338CF">
    <domeo:uuid>A03AB529-B51D-495B-88D7-404C443338CF</domeo:uuid>
    <ao:exact>-</ao:exact>
    <pav:createdOn>2014-07-07 09:42:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A03AB529-B51D-495B-88D7-404C443338CF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA1C9791-9797-4F15-A767-767B900E9B87">
    <ao:exact>-</ao:exact>
    <pav:createdOn>2014-07-07 09:58:58 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>EA1C9791-9797-4F15-A767-767B900E9B87</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EA1C9791-9797-4F15-A767-767B900E9B87"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B2918C2-A28D-40C3-8147-F19D09B7119C">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A3612760-5AFD-415B-8269-F1483D859C5D"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:D33635C9-431B-4949-93E0-2DE8680E9651</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:37:58 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA428F64-D782-46F5-B866-2FBC24D3F4F8">
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:9F3CAE5F-12DF-463B-A0AD-4F223784EC31</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:58:58 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EA1C9791-9797-4F15-A767-767B900E9B87"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0605CFD4-BB68-443D-9ABF-C97A7A0563B0">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E5FE9EFB-83B0-4935-97F9-6C46842B3260"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D480921-AA61-499B-9C3F-3043269104B4">
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:CFAD9029-E218-4465-9975-0A69DA967891"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:40:13 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:AB0B3697-93C5-4EDB-AE47-84A16A407797</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED359A65-2894-4EE7-9430-453B2C8C6D26">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 12:40:24 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>ED359A65-2894-4EE7-9430-453B2C8C6D26</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ED359A65-2894-4EE7-9430-453B2C8C6D26"/>
    <ao:exact>In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BD1E279-39ED-4853-AF2E-BE56BEB4AF03">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:7687B2A2-948F-4E07-9BC1-43216AD31878</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:11:31 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:159DCA30-3727-4241-9440-301E40381956"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D83441D-0916-4D83-A136-CA26588E67D0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0D83441D-0916-4D83-A136-CA26588E67D0"/>
    <ao:suffix> combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <pav:createdOn>2014-07-13 11:13:49 -0400</pav:createdOn>
    <domeo:uuid>0D83441D-0916-4D83-A136-CA26588E67D0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E08DAB4-201F-48CD-8ACA-375750DA65B1">
    <ao:suffix>(50 mg) to healthy volunteers.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 11:22:56 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E08DAB4-201F-48CD-8ACA-375750DA65B1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>3E08DAB4-201F-48CD-8ACA-375750DA65B1</domeo:uuid>
    <ao:prefix>concentrations when co-administered with </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62F3C932-C305-4581-AA4E-BB34C6D0F7D4">
    <domeo:uuid>62F3C932-C305-4581-AA4E-BB34C6D0F7D4</domeo:uuid>
    <pav:createdOn>2014-07-07 11:22:45 -0400</pav:createdOn>
    <ao:exact>TID </ao:exact>
    <ao:prefix>exposure without concomitant medication is shown to be 5-fold higher at a dose of 80 mg </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>compared to its exposure at a dose of 20 mg </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:62F3C932-C305-4581-AA4E-BB34C6D0F7D4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42DD4654-83AE-4111-86D8-574617EB3CAB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in </ao:prefix>
    <domeo:uuid>42DD4654-83AE-4111-86D8-574617EB3CAB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 12:56:03 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix> AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole hal</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42DD4654-83AE-4111-86D8-574617EB3CAB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB66F52A-826A-4B19-9DAB-4F305456531E">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A5C90995-9DDD-408E-A19C-6AA024D77686</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:40519342-F06B-41D2-A39A-795BA218AF7B"/>
    <pav:createdOn>2014-07-13 12:46:18 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CC41192-004E-44F9-8E3D-0FF7CECF1DC2">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:13:30 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:2E085178-1D00-47D7-8B18-1A094C6C93A7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3F94F7A-3299-4ECD-8A0C-54D9B0E17A6D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A54DB360-9E9B-4E55-AC79-A80E321825D3">
    <pav:createdOn>2014-07-13 12:38:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>norethindrone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:suffix> increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosi</ao:suffix>
    <domeo:uuid>A54DB360-9E9B-4E55-AC79-A80E321825D3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A54DB360-9E9B-4E55-AC79-A80E321825D3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EA46EFB-1A94-409D-B432-24203EA5400F">
    <ao:context rdf:resource="urn:domeoclient:uuid:8A7AE105-ADC2-416B-AD5B-0B0B1DB2A2E2"/>
    <pav:lineageUri>urn:domeoserver:annotation:0DE5D981-90C9-4EFB-8436-D8AEB6978507</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 12:38:56 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB359BC3-6C0F-427E-B961-0838B54690D5">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BB359BC3-6C0F-427E-B961-0838B54690D5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Single oral doses of </ao:prefix>
    <domeo:uuid>BB359BC3-6C0F-427E-B961-0838B54690D5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG. After chronic dosing of 80 mg TID to patients with pulmonary arterial hypertension, no clinically relevant effects on ECG were reported.</ao:suffix>
    <pav:createdOn>2014-07-07 09:38:27 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B3435A02-DBAF-4D33-9A80-3B78037721AE">
    <domeo:uuid>B3435A02-DBAF-4D33-9A80-3B78037721AE</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B3435A02-DBAF-4D33-9A80-3B78037721AE"/>
    <ao:exact>Risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> acts as an antagonist at other receptors, but with lower potency. Risperidone has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-</ao:suffix>
    <pav:createdOn>2014-07-13 11:07:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:098AA784-6695-4935-9450-C87D502EDBCD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>erythromycin</ao:exact>
    <ao:suffix>, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC).</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 11:23:07 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:098AA784-6695-4935-9450-C87D502EDBCD"/>
    <ao:prefix>was co-administered with </ao:prefix>
    <domeo:uuid>098AA784-6695-4935-9450-C87D502EDBCD</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49F82F74-6EDD-4994-8052-10CB1FCA4BA0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:09:11 -0400</pav:createdOn>
    <domeo:uuid>49F82F74-6EDD-4994-8052-10CB1FCA4BA0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> is well absorbed. The absolute oral bioavailability of risperidone is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <ao:prefix>Absorption: </ao:prefix>
    <ao:exact>Risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:49F82F74-6EDD-4994-8052-10CB1FCA4BA0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0AC105E-C659-4D3F-9F13-4104BCC29CDE">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:6A3A3F06-7277-4FF9-9E27-EBB7510D87E7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 11:13:36 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:65044E3B-BE66-455E-B576-1B8DF996B6B4"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0DCB0F4-61CC-48CE-8688-567F2327B321">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:prefix> AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of </ao:prefix>
    <ao:exact>cimetidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C0DCB0F4-61CC-48CE-8688-567F2327B321"/>
    <domeo:uuid>C0DCB0F4-61CC-48CE-8688-567F2327B321</domeo:uuid>
    <pav:createdOn>2014-07-13 12:46:27 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95AEC430-A2F4-4B0D-B623-70050D7B891E">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:18:24 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC861D6D-4076-4F69-B134-B404C685F91A"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:EB8C6594-359A-42D0-A03E-A9374296DDDA</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ED3BCC98-B0FE-4421-B54B-7B2414CF4328">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>norethindrone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7514</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9FE917E-CAFF-4C8B-B16B-BB0606212145">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:43:59 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C29885C9-C34F-446F-88D0-5C6DE9D91033"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:B87E8C78-2AB2-4100-9E1E-BE2714EEBB4B</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:464ED203-77EC-4EFC-873A-7853A308DCA5">
    <pav:lineageUri>urn:domeoserver:annotation:A434E784-EF19-4D9F-9D9A-D71E320A8599</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:17:56 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F63A36F-F819-4E40-9C8A-C518B5519787"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E2F95CEA-24A5-407F-856C-8C142EEA5626">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2ABA1A35-6C77-4A0A-9EC5-109AA13136B6">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:6129321F-FF20-473A-89DA-A79D75F63074</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:58:59 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D3737933-330F-487F-B41C-CDB0FF5C6F1C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BDA75ADA-742A-402B-AE97-4438F99C61FC">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:36:02 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:3A5ED499-A47F-47B9-8A20-DE5C5355E048</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3EBDA2ED-165F-4B57-B4BE-CFA63CD5C5A6"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:AF657FF8-3529-4A9B-9294-13C604834E0A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:66EBA4F6-77AF-4AB4-A3E8-E0D406200FF6</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:962DC691-3D08-4224-8D22-C0DD8D9F24CA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:35685454-E730-4B12-A923-46EE9655234C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A1F4E1-991C-4D93-AC6A-4DEDDF392601"/>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="N89a3162a6ce943a3930a1b08d1fb698a"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70919722-5B5F-4E86-A52F-8A64A1EFDA72"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:B4E5EBBF-965D-41F8-B54E-0CF48653C43C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1836E85-2D43-46EF-848C-F6204E5A50A7"/>
    <pav:createdOn>2014-07-13 12:55:59 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:11E26B74-9DE2-4B10-A8C9-A250D2747B3E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3762570C-CF43-4DB9-B163-FAA6DAE60017">
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:28EA3105-DAE4-4248-8C5A-EACDF44B4680"/>
    <pav:lineageUri>urn:domeoserver:annotation:65E1DF4C-ED97-45AE-A88B-0EE9DF979CD2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:39:29 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:190DDFDA-8456-4B27-972C-5E815FA29EBD">
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 12:47:19 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:6778C161-ADEE-4D2A-83DD-90876C90F77A</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:5039F6DC-F654-4E38-8762-0E1BD92F058C"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N5d289d8aebe34c1fb3f0e0c245c38156"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08713DDF-0935-4B63-B281-AEE56A8D7628">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:58:53 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A6C1D994-FD1E-4778-8CFC-8AF61A3DA42E</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:6BF6E19B-3833-4401-A589-B16E9522C485"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE5C582E-1F4C-478C-9DDC-DAB4C0C1ABFF">
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:AA9BE1F2-854A-4E7D-8C64-DCE1158C5D96"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:58:57 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:FFE74587-6133-48F1-B1FA-716CCC2AA2F3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A22D7450-FC77-45A4-B835-3948870AD344">
    <ao:exact>Sertraline</ao:exact>
    <ao:suffix> hydrochloride is supplied for oral administration as scored tablets containing sertraline hydrochloride equivalent to 25, 50, 100, 150 and 200 mg of sertraline and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl ce</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A22D7450-FC77-45A4-B835-3948870AD344"/>
    <domeo:uuid>A22D7450-FC77-45A4-B835-3948870AD344</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 12:34:35 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70919722-5B5F-4E86-A52F-8A64A1EFDA72">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C1C706B9-7F27-4C22-8F0D-E46B96B35A86"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:34E978B5-2DD2-44FE-B1ED-248C51C20EC2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 12:56:11 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56FE6B9A-96B3-43BC-A4E1-A9AFE78680CE">
    <ao:prefix> to </ao:prefix>
    <ao:suffix> [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>56FE6B9A-96B3-43BC-A4E1-A9AFE78680CE</domeo:uuid>
    <pav:createdOn>2014-07-13 11:14:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:56FE6B9A-96B3-43BC-A4E1-A9AFE78680CE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E76D782E-ADBF-42D0-9CCA-8944F07D22DA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B98C3482-C44D-4C61-ACC3-D277890BCE91"/>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 11:23:25 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:D0DD21B4-2DEA-49DA-B4BC-07501CC0DD24</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3ED57AC4-296D-4C8D-9873-49C193F69BBA">
    <ao:context rdf:resource="urn:domeoclient:uuid:CE972F8D-C1AD-46A9-B34B-1D883FDAF1EC"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:40:14 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:EDAFE895-630D-4E68-A004-9114AFE7F495</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7CBD8092-1453-4994-9F29-22622E743A15">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/94DFD21D-D749-4F5E-AE57-CF5CE30BA0D9"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B7CB635F-4EBF-434B-9159-71DC46A33588"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:68010F53-B903-4110-B73F-5CE843CA2E18">
    <ao:prefix>is 105 L, indicating distribution into the tissues. </ao:prefix>
    <pav:createdOn>2014-07-07 09:42:08 -0400</pav:createdOn>
    <ao:suffix>and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:68010F53-B903-4110-B73F-5CE843CA2E18"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>68010F53-B903-4110-B73F-5CE843CA2E18</domeo:uuid>
    <ao:exact>Sildenafil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACB2EB18-2590-4CF8-9CB3-0EF209C089E0">
    <ao:suffix>nitrates [see Contraindications (4)].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>concomitant </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ACB2EB18-2590-4CF8-9CB3-0EF209C089E0"/>
    <ao:prefix>, therefore the effects are not related to dose or plasma levels within this dosage range. Larger effects were recorded among patients receiving </ao:prefix>
    <pav:createdOn>2014-07-07 09:38:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>ACB2EB18-2590-4CF8-9CB3-0EF209C089E0</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F1504F1A-B189-4B6A-9973-4A17775240C5">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5AC4FDB3-99BB-4CC2-9A03-87893DB04756">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76B68D47-1D9C-4B2A-B9A6-CFE359C93E64">
    <pav:createdOn>2014-07-13 12:56:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. There was a mean ± SD reduction in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <domeo:uuid>76B68D47-1D9C-4B2A-B9A6-CFE359C93E64</domeo:uuid>
    <ao:suffix> AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76B68D47-1D9C-4B2A-B9A6-CFE359C93E64"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECF8E578-9A91-41E0-91AC-502E097E5A11">
    <pav:createdOn>2014-07-07 11:23:40 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>ECF8E578-9A91-41E0-91AC-502E097E5A11</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ECF8E578-9A91-41E0-91AC-502E097E5A11"/>
    <ao:prefix>Injection: Predictions based on a pharmacokinetic model suggest that drug-drug interactions with CYP3A inhibitors will be less than those observed after oral </ao:prefix>
    <ao:suffix>administration.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74FDA5BD-9C18-4F10-AC59-C5C75AA497C2">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:5CD942C6-D369-4ED6-B77B-FB216085FF48</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-07 11:24:14 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0CCA954-EB0E-4D16-9B00-C1E4BE4A989D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:211F5FD6-FC29-4AC5-96E1-14E088108ABB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>211F5FD6-FC29-4AC5-96E1-14E088108ABB</domeo:uuid>
    <pav:createdOn>2014-07-13 12:56:54 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:211F5FD6-FC29-4AC5-96E1-14E088108ABB"/>
    <ao:suffix> (See PRECAUTIONS.</ao:suffix>
    <ao:exact>Administration of a single oral 200 mg dose of fluconazole after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours.</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72594949-CA92-4CEF-8CB6-0072661759A0">
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 12:38:31 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:72C81315-5D14-41CA-AEB9-E23AC335F4C3"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:4A02C183-A585-4567-848A-3878478E06F5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5039F6DC-F654-4E38-8762-0E1BD92F058C">
    <pav:createdOn>2014-07-13 12:47:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:prefix> 400 mg to six healthy male volunteers. </ao:prefix>
    <ao:exact>After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%).</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> However, the administration of</ao:suffix>
    <domeo:uuid>5039F6DC-F654-4E38-8762-0E1BD92F058C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5039F6DC-F654-4E38-8762-0E1BD92F058C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B743E18-8323-4761-B0A4-3B200C16F9BE">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:16FE2F0D-3BF4-4708-9147-BD5159B47059"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:9644563B-1E1E-4AF0-871E-E395B93BB653</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:14:31 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D37CC60-618E-46B6-8C99-BA7D598E3762">
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:23:40 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:DDCCCF49-E95D-4DE0-8F83-128C04E4F1DB</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:ECF8E578-9A91-41E0-91AC-502E097E5A11"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D7139F9-BDC3-437F-A5A1-D75EDAC972B0">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:18699EA6-5F06-460B-B2AD-992A44EC2FCD</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 11:07:46 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B3435A02-DBAF-4D33-9A80-3B78037721AE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFAD9029-E218-4465-9975-0A69DA967891">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>CFAD9029-E218-4465-9975-0A69DA967891</domeo:uuid>
    <ao:prefix>After chronic dosing of 80 mg </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>TID </ao:exact>
    <pav:createdOn>2014-07-07 09:40:13 -0400</pav:createdOn>
    <ao:suffix>sildenafil to patients with systemic hypertension, the mean change from baseline in systolic and diastolic blood pressures was a decrease of 9.4 mmHg and 9.1 mmHg, respectively.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CFAD9029-E218-4465-9975-0A69DA967891"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D78CEABF-EE24-4AFF-81A9-B148050EFE16">
    <ao:exact>phenytoin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D78CEABF-EE24-4AFF-81A9-B148050EFE16</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D78CEABF-EE24-4AFF-81A9-B148050EFE16"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:15:52 -0400</pav:createdOn>
    <ao:suffix>, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/83E9958D-5BAA-415C-B14A-C204CC3ED68C">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0B517A8-DCD4-4740-A77D-8490A77113AE">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 12:40:40 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:8D387F71-D7EF-42BB-8B40-0EBCAFF64A75</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Neb2778f97e154b1190ba1db6604ff6fa"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:CAB91F57-2F70-4DDB-9BF8-A50167C8BBCE"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:366925ED-C6A8-41CA-97EB-602399B8DB72">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:366925ED-C6A8-41CA-97EB-602399B8DB72"/>
    <domeo:uuid>366925ED-C6A8-41CA-97EB-602399B8DB72</domeo:uuid>
    <ao:suffix> and its metabolites are eliminated via the urine and, to a much lesser extent, via the feces. As illustrated by a mass balance study of a single 1 mg oral dose of 14C-risperidone administered as solution to three healthy male volunteers, total recovery </ao:suffix>
    <pav:createdOn>2014-07-13 11:16:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>Risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Excretion: </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9174469-54E0-4FAB-8165-210C50F1F809"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EA46EFB-1A94-409D-B432-24203EA5400F"/>
    <permissions:permissions rdf:nodeID="N8070f72a9470415a816914e8fda9eb15"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:createdOn>2014-07-13 12:35:54 -0400</pav:createdOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:4EEAF739-3D04-465D-8AC0-35EAE4B00AE0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12FA04F1-54A6-4C48-9FDA-8E372C8A648A"/>
    <pav:lastSavedOn>2014-07-13 12:41:09 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:76D2A20E-E18E-4676-958D-12D182D20430"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C0B517A8-DCD4-4740-A77D-8490A77113AE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E38DB7B-2B38-491B-8686-9C2D434ACD79"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3CE3E7D7-79CE-4BA9-8CA0-7B7A05D77AFC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6BF180C6-926E-4F67-84B0-1DC9E664C663"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:167FB68A-5943-4F0E-8CC6-C6BAB7625E4F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3BEBBBC1-7503-4FA0-9B16-ED708F2AE108"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA8337B7-4497-4F34-93E8-291B9ED278CB"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:7698170F-5CE1-49C4-9F55-5ED355B5BEA7</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:C7A86B1F-FEF9-4500-AC47-4A4949A51ABD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:72594949-CA92-4CEF-8CB6-0072661759A0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E5DE379E-8BB3-4609-BFC6-A0E275978ADC">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1A7382E8-45D1-4872-98EA-20455089A06B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 11:23:45 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C1698FA2-C1AE-4B3D-9950-C56ECC1CFB3C</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64792593-BEAB-4B65-88FB-A2254663F469">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:DFB0D433-995A-4EB5-B9CC-EAE5A0C16DEA"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:12:29 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C65DDEB0-B97A-4B57-9CA0-73F44448001C</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2CE66065-C68D-4E90-911C-F8B5E04B3813">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>2CE66065-C68D-4E90-911C-F8B5E04B3813</domeo:uuid>
    <ao:suffix>. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared</ao:suffix>
    <ao:exact>norethindrone</ao:exact>
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 12:37:33 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2CE66065-C68D-4E90-911C-F8B5E04B3813"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7A86B1F-FEF9-4500-AC47-4A4949A51ABD">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 12:38:35 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:A54DB360-9E9B-4E55-AC79-A80E321825D3"/>
    <pav:lineageUri>urn:domeoserver:annotation:47D86654-5774-44C8-91EF-5162D998152D</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02D92735-6D44-4DFA-A2E9-75A5A3D4DCF9">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC34C3D8-C58F-483B-80DB-B65FEBB2EC20"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:42:51 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:21A31B97-1130-4A1C-93A0-70A39037EF29</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2A93D3C-935C-417F-BE1B-282EDBEB8D85">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:14:04 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:56FE6B9A-96B3-43BC-A4E1-A9AFE78680CE"/>
    <pav:lineageUri>urn:domeoserver:annotation:12676179-27AE-44BF-86DE-5AE7A37D1457</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2532730F-81C6-4CC5-93B2-FC3A19B98EC5">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:FA839309-7C8B-4446-A5C1-08694E7B8482"/>
    <pav:createdOn>2014-07-13 11:09:57 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:2080DF37-EAA6-443D-A391-2897A81CAD23</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A151EB77-7400-49F2-9673-BFAD2171D5CD">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:07:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:17F49268-30E8-4066-B9B1-4521C34B09E9</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:A3654752-C204-49F0-B3F7-87C2EE277992"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B4D9B85-636E-45EE-9796-1A7AE7E45DCF">
    <domeo:uuid>1B4D9B85-636E-45EE-9796-1A7AE7E45DCF</domeo:uuid>
    <pav:createdOn>2014-07-13 11:11:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> (10 mcg/mL) caused only a slight increase in the free fraction of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1B4D9B85-636E-45EE-9796-1A7AE7E45DCF"/>
    <ao:suffix> at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6791DC23-BC40-4E62-815B-0DA5CCA7BD4F">
    <ao:suffix>is taken with a high-fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%. The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the ti</ao:suffix>
    <domeo:uuid>6791DC23-BC40-4E62-815B-0DA5CCA7BD4F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6791DC23-BC40-4E62-815B-0DA5CCA7BD4F"/>
    <ao:exact>REVATIO </ao:exact>
    <pav:createdOn>2014-07-07 09:41:41 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%). Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79293219-D172-4E27-A045-D16B4F539C60">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E2AC08E4-8A5F-4E68-B2F1-20AFB690BAC7"/>
    <pav:lineageUri>urn:domeoserver:annotation:A98BA61A-C2C5-4182-B0E9-6095CE94E0D1</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 11:22:40 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:007F6835-1CAF-4F0B-8BFD-311D8BFD8926">
    <ao:suffix>was co-administered with erythromycin, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC).</ao:suffix>
    <pav:createdOn>2014-07-07 11:23:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>007F6835-1CAF-4F0B-8BFD-311D8BFD8926</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:007F6835-1CAF-4F0B-8BFD-311D8BFD8926"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:prefix>When a single 100 mg dose of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F4EA581-2F5C-4FF1-8DA3-D5101E760F69">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and its major metabolite, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F4EA581-2F5C-4FF1-8DA3-D5101E760F69"/>
    <domeo:uuid>5F4EA581-2F5C-4FF1-8DA3-D5101E760F69</domeo:uuid>
    <ao:suffix> [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:28:14 -0400</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B294F73B-169E-4106-90EF-3C87099953E8">
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B294F73B-169E-4106-90EF-3C87099953E8"/>
    <domeo:uuid>B294F73B-169E-4106-90EF-3C87099953E8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:29:18 -0400</pav:createdOn>
    <ao:suffix> Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone</ao:suffix>
    <ao:exact>The clinical effect from risperidone results from the combined concentrations of risperidone and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY].</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9174469-54E0-4FAB-8165-210C50F1F809">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 12:37:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:2051B080-40BC-4A2C-B53F-A08613EB9C84</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2CE66065-C68D-4E90-911C-F8B5E04B3813"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94239CD6-2883-459B-A125-FF55B9791833">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D909BDC5-468E-434E-B3E5-632F1565E73C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:11:25 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4B9E6D9B-AF88-4692-9DEF-8B6FA5D8F2B7</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N89a3162a6ce943a3930a1b08d1fb698a">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8D05CE4-8287-449A-8921-AFACBAEE2002">
    <pav:createdOn>2014-07-07 09:39:32 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:02608C01-A84B-4FA5-B484-E8E8B6A81DF4</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:52192391-30EB-46A9-93CB-47EC77CE40BC"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:99E97745-423E-4818-BFC6-3F67C8BF2A87">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:11:00 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:EAD485AF-D5DA-435A-B47D-F022CCE0E626</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:8ED4F58C-10A8-4F3A-8776-FD6D08A25610"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57242808-9748-4ED3-908E-E0054E0C8BBE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 12:46:37 -0400</pav:createdOn>
    <ao:prefix> 200 mg) did not affect the bioavailability or pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:57242808-9748-4ED3-908E-E0054E0C8BBE"/>
    <domeo:uuid>57242808-9748-4ED3-908E-E0054E0C8BBE</domeo:uuid>
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix> in 24 healthy male volunteers.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1554FCFD-7477-413C-879A-913DFFAB5886">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>1554FCFD-7477-413C-879A-913DFFAB5886</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1554FCFD-7477-413C-879A-913DFFAB5886"/>
    <ao:prefix>, a CYP3A inhibitor, at steady state (1200 mg TID) with </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>(100 mg single dose) resulted in a 140% increase in sildenafil Cmax and a 210% increase in sildenafil AUC.</ao:suffix>
    <pav:createdOn>2014-07-07 11:24:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55E300CE-2A8F-42F4-9877-A49DDE4F3360">
    <pav:createdOn>2014-07-07 11:24:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:7897E8BB-DD46-4B51-BE6D-8D92A1B57431</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:76A2A466-4D5D-4AA1-8114-FAD1FF0E6FC0"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1d2fcb8abfd9458e9e6075fe42cbca0c">
    <domeo:sets rdf:resource="urn:pddi:uuid:125C14DB-1F35-4667-846F-F789D6D0AFCF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFB0D433-995A-4EB5-B9CC-EAE5A0C16DEA">
    <ao:suffix> plus 9-hydroxyrisperidone.</ao:suffix>
    <ao:prefix>. Consequently, the clinical effect of the drug results from the combined concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:12:29 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DFB0D433-995A-4EB5-B9CC-EAE5A0C16DEA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>DFB0D433-995A-4EB5-B9CC-EAE5A0C16DEA</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A0AE7AB-260B-4296-BC83-DB443FEE5161">
    <pav:createdOn>2014-07-13 12:46:24 -0400</pav:createdOn>
    <ao:exact>fluconazole</ao:exact>
    <domeo:uuid>6A0AE7AB-260B-4296-BC83-DB443FEE5161</domeo:uuid>
    <ao:prefix> AUC and Cmax. There was a mean ± SD decrease in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of flucon</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6A0AE7AB-260B-4296-BC83-DB443FEE5161"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2C79BAB-965C-479E-824A-F2884B348419">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E2C79BAB-965C-479E-824A-F2884B348419</domeo:uuid>
    <ao:prefix> increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. </ao:prefix>
    <ao:suffix> treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatm</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E2C79BAB-965C-479E-824A-F2884B348419"/>
    <pav:createdOn>2014-07-13 12:38:39 -0400</pav:createdOn>
    <ao:exact>Fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20B4F69C-E14E-46A0-8FCE-6AAC4D5EF0B0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>After chronic dosing of 80 mg </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>20B4F69C-E14E-46A0-8FCE-6AAC4D5EF0B0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>sildenafil to patients with pulmonary arterial hypertension, lesser reductions than above in systolic and diastolic blood pressures were observed (a decrease in both of 2 mmHg).</ao:suffix>
    <pav:createdOn>2014-07-07 09:40:23 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20B4F69C-E14E-46A0-8FCE-6AAC4D5EF0B0"/>
    <ao:exact>TID </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FBE9544-4653-482C-B065-70CA3AA07309">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:15:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs meta</ao:suffix>
    <domeo:uuid>5FBE9544-4653-482C-B065-70CA3AA07309</domeo:uuid>
    <ao:prefix>, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5FBE9544-4653-482C-B065-70CA3AA07309"/>
    <ao:exact>rifampin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71E5047C-5690-4D45-9A6E-FB1384C14928">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A268B82-4B69-4D00-A6E9-95F225012877"/>
    <pav:lineageUri>urn:domeoserver:annotation:DFC21707-69A6-4E64-9438-1D6C69F0352F</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:16:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0124DF91-B793-47E7-9547-2BF080146FA7">
    <domeo:uuid>0124DF91-B793-47E7-9547-2BF080146FA7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0124DF91-B793-47E7-9547-2BF080146FA7"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:12:20 -0400</pav:createdOn>
    <ao:suffix>, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results from the combined concentrations of risperidone plus 9-hydroxyrisperidone.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35685454-E730-4B12-A923-46EE9655234C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 12:56:13 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB3EAD78-45A5-439B-B26A-FE0BB9EDCBD0"/>
    <pav:lineageUri>urn:domeoserver:annotation:2703BC23-B5BF-482E-A701-F416ADF738D1</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6BF180C6-926E-4F67-84B0-1DC9E664C663">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 12:38:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:B86B4616-9A36-459A-BD9A-3E75A70DBB8E</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E2C79BAB-965C-479E-824A-F2884B348419"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52192391-30EB-46A9-93CB-47EC77CE40BC">
    <domeo:uuid>52192391-30EB-46A9-93CB-47EC77CE40BC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>TID </ao:exact>
    <pav:createdOn>2014-07-07 09:39:32 -0400</pav:createdOn>
    <ao:prefix>After chronic dosing of 80 mg </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:52192391-30EB-46A9-93CB-47EC77CE40BC"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE717566-90D0-4B59-B00F-B053CAE639C4">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:D7AEA2C8-0FF3-482D-BC96-255927C0D5D8</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:13:49 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0D83441D-0916-4D83-A136-CA26588E67D0"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:984E4D2D-A998-4068-9BF7-F709348DD1B2">
    <ao:suffix> and 9-hydroxyrisperidone was decreased, and elimination half-lives were prolonged compared to young healthy subjects. Dosing should be modified accordingly in the elderly patients [see 2 DOSAGE AND ADMINISTRATION].</ao:suffix>
    <pav:createdOn>2014-07-13 11:18:21 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>984E4D2D-A998-4068-9BF7-F709348DD1B2</domeo:uuid>
    <ao:prefix>Elderly: In healthy elderly subjects, renal clearance of both </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:984E4D2D-A998-4068-9BF7-F709348DD1B2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8380B817-2385-42D1-ACFB-89134B65210A">
    <pav:createdOn>2014-07-07 09:42:37 -0400</pav:createdOn>
    <ao:exact>-</ao:exact>
    <domeo:uuid>8380B817-2385-42D1-ACFB-89134B65210A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8380B817-2385-42D1-ACFB-89134B65210A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72843AE3-90CC-43FD-BCEC-E83B4E3A7EDF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:7D999E14-4D2E-4EE2-945B-2011BD864F5E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:10:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:77F990A5-C7A6-4873-A32F-AD9607EFDE51"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:934B866B-AFCB-4F4A-A5CA-1B312B3088E1">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:AD145E05-D965-40D9-8AB9-4C610AF8A665</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:A0EE858B-D738-4E79-B01E-E50A3141586B"/>
    <pav:createdOn>2014-07-13 11:15:01 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B5E75366-F0BF-442F-852E-19C5EDDC84EE">
    <pav:createdOn>2014-07-07 09:42:24 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C4441B5B-C18F-4F66-90A8-3A3306CD1C90"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:3190AAB5-A173-4B55-B90B-ADA3F02C967F</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B475492-95FE-4CDD-81AE-94DFEEB91E11">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:09:25 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:46780EA4-462F-4B55-AB22-23CB7FC82C80"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:D6AADC58-2D29-4DC9-83E4-5252DDC68D2C</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57E98049-37B0-4F70-963B-F0D12C3B36C7">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:996E26F9-829E-4D62-867F-4975211CECA5</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 11:22:43 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:EFE95BF7-1349-414E-B68F-6C5149A03072"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC416A29-1315-42C5-90FA-652412A6AD12">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5921BA7A-A507-4387-9FEF-14A8A1423763</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 09:40:48 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8EA1563F-47E7-4983-918E-643A5D2021DC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D16208CB-7392-415A-8487-52928A419F00">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D16208CB-7392-415A-8487-52928A419F00</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-13 12:46:12 -0400</pav:createdOn>
    <ao:exact>Fluconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D16208CB-7392-415A-8487-52928A419F00"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:suffix> 100 mg was administered as a single oral dose alone and two hours after a single dose of cimetidine 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5E38DB7B-2B38-491B-8686-9C2D434ACD79">
    <pav:lineageUri>urn:domeoserver:annotation:B018D6F2-5667-4118-9A44-AD32984915AA</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N9aba69a11243475fad98519abd892ac5"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:ED359A65-2894-4EE7-9430-453B2C8C6D26"/>
    <pav:createdOn>2014-07-13 12:40:24 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F1DD8EF-72E2-425B-B98B-233F1591A13F">
    <ao:prefix>is taken with a high-fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%. The mean steady state volume of distribution (Vss) for </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>8F1DD8EF-72E2-425B-B98B-233F1591A13F</domeo:uuid>
    <pav:createdOn>2014-07-07 09:42:06 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F1DD8EF-72E2-425B-B98B-233F1591A13F"/>
    <ao:suffix>is 105 L, indicating distribution into the tissues. Sildenafil and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9D56D7C-5C37-4BCA-B9C4-0605E9E54998">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil</ao:exact>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>B9D56D7C-5C37-4BCA-B9C4-0605E9E54998</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, and is, itself, further metabolized. This metabolite has a phosphodiesterase selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% of the parent drug. In healthy volunteers, plasma concentrations of this metabolit</ao:suffix>
    <pav:createdOn>2014-07-07 09:43:42 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B9D56D7C-5C37-4BCA-B9C4-0605E9E54998"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3612760-5AFD-415B-8269-F1483D859C5D">
    <ao:exact>sildenafil</ao:exact>
    <domeo:uuid>A3612760-5AFD-415B-8269-F1483D859C5D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>iastolic blood pressure of 8/5 mmHg). The decrease in blood pressure was most notable approximately 1–2 hours after dosing, and was not different from placebo at 8 hours. Similar effects on blood pressure were noted with 25 mg, 50 mg and 100 mg doses of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, therefore the effects are not related to dose or plasma levels within this dosage range. Larger effects were recorded among patients receiving concomitant nitrates [see Contraindications (4)].</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:37:58 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A3612760-5AFD-415B-8269-F1483D859C5D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEDA4663-FBED-4C68-848C-30943B88C061">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EEDA4663-FBED-4C68-848C-30943B88C061"/>
    <domeo:uuid>EEDA4663-FBED-4C68-848C-30943B88C061</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:10:25 -0400</pav:createdOn>
    <ao:suffix> are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabolizers. Steady-state concentrations of 9-hydroxyrisperidone are reached in 5 to 6 days (measured in extensive metabolizers).</ao:suffix>
    <ao:prefix> occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A">
    <permissions:permissions rdf:nodeID="Nb25235f9e1a145a79bfdc2c872bf952b"/>
    <pav:createdOn>2014-07-13 12:41:59 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:2EC3D9EC-E1A7-4DD1-A006-50B08564335E"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:CE4C4228-2925-4DF5-84E2-5A5B519C5595</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0E54D90-28C4-48FD-B72C-21011511DD58"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A0645479-B3CA-4505-B451-B003C3B19554"/>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A5707CC-D3AC-4807-9E98-6536CDC7AC55"/>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:010AF63D-C71E-4A93-9F41-8E5764F068ED"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:1B6E9A08-C112-4656-8901-F8802CD64317"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB4AA59B-BD34-4506-A617-157D639949C4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:67CFE2D6-F2AA-4465-A433-B26BEA64FB5E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92530361-A562-40CE-942A-CC181EBE7AD7">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:6A05795B-B1AB-4DB3-A12F-2765CBCC2FED</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 12:34:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A22D7450-FC77-45A4-B835-3948870AD344"/>
    <pav:lastSavedOn>2014-07-13 12:34:42 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:FB9B5330-BB9D-4DA0-8780-703069BE2890</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97C1D6A3-E462-4C1F-8DD6-513D5AD2268A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:07:54 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F63AE259-E4D8-48C8-9143-FADBBFAD548B"/>
    <pav:lineageUri>urn:domeoserver:annotation:693FA6F8-074D-41A3-9AF3-2256D761F345</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE5A4249-D765-40E0-B39A-F0725082F558">
    <pav:lineageUri>urn:domeoserver:annotation:9B9C1209-F5B5-4C60-96C7-DD33A9BFB63C</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:AA5EEC38-13CE-4D77-8996-A3CFF229A32F"/>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:34:23 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/021311B6-82A4-4AA1-97CE-B7A322F4EE50">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>erythromycin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72C81315-5D14-41CA-AEB9-E23AC335F4C3">
    <pav:createdOn>2014-07-13 12:38:31 -0400</pav:createdOn>
    <ao:suffix> and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compar</ao:suffix>
    <ao:prefix> compared to similar placebo dosing. The mean AUCs of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ethinyl estradiol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>72C81315-5D14-41CA-AEB9-E23AC335F4C3</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:72C81315-5D14-41CA-AEB9-E23AC335F4C3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54B9529D-9030-4194-B66A-D7ECCBABED1F">
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:DBBBE91C-3E2F-469A-9254-58328E372FEA"/>
    <pav:createdOn>2014-07-07 09:37:41 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:97175F26-BD6F-4CA9-819A-E5E6892969B4</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EBDA4EF3-E793-47E4-9F6F-74592DE48307">
    <ao:suffix> AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <ao:exact>ethinyl estradiol</ao:exact>
    <domeo:uuid>EBDA4EF3-E793-47E4-9F6F-74592DE48307</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EBDA4EF3-E793-47E4-9F6F-74592DE48307"/>
    <pav:createdOn>2014-07-13 12:44:29 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:prefix>. The mean increase in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89155DC0-3493-4590-8DD7-44717F141C27">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0A1E742B-4ABE-40BF-84E5-2A5F57F232F2"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:94085E4A-F1A0-40E6-8805-C846AF27EEDD</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:09:15 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1836E85-2D43-46EF-848C-F6204E5A50A7">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:67C91220-39BA-4E36-AF83-B063DCBE7679</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 12:56:03 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:42DD4654-83AE-4111-86D8-574617EB3CAB"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F31EE1EC-A22F-4FE9-8763-7C623AD7B0BE">
    <pav:createdOn>2014-07-13 11:08:54 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F31EE1EC-A22F-4FE9-8763-7C623AD7B0BE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> results from the combined concentrations of </ao:prefix>
    <domeo:uuid>F31EE1EC-A22F-4FE9-8763-7C623AD7B0BE</domeo:uuid>
    <ao:suffix> and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:195005D8-3CE9-43AD-A3D8-56739DB440A4">
    <pav:createdOn>2014-07-13 12:44:25 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <domeo:uuid>195005D8-3CE9-43AD-A3D8-56739DB440A4</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> AUC after the administration of 50 mg of </ao:prefix>
    <ao:suffix>. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:195005D8-3CE9-43AD-A3D8-56739DB440A4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E13140FE-59B4-45B2-A524-CAED051C4F9D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:42:08 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:54480EEE-DF3F-4931-84CB-D1B1770AE31E</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:68010F53-B903-4110-B73F-5CE843CA2E18"/>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5139C7C3-ACE5-4F03-BC84-8DD2AF187DDB">
    <ao:exact>Cimetidine </ao:exact>
    <ao:suffix>(800 mg), a nonspecific CYP inhibitor, caused a 56% increase in plasma sildenafil concentrations when co-administered with sildenafil (50 mg) to healthy volunteers.</ao:suffix>
    <pav:createdOn>2014-07-07 11:22:50 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5139C7C3-ACE5-4F03-BC84-8DD2AF187DDB"/>
    <domeo:uuid>5139C7C3-ACE5-4F03-BC84-8DD2AF187DDB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2EC3D9EC-E1A7-4DD1-A006-50B08564335E">
    <pav:lineageUri>urn:domeoserver:annotation:01F5BBDB-E20A-4996-9E0A-81199182C6B7</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 12:44:35 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:E17F3ACA-8486-4702-886B-6FA2562FDEFF"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78BBB6BD-543C-42F3-B5F5-431ADE5F4D72">
    <pav:createdOn>2014-07-13 11:12:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results from the combined concentr</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78BBB6BD-543C-42F3-B5F5-431ADE5F4D72"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>78BBB6BD-543C-42F3-B5F5-431ADE5F4D72</domeo:uuid>
    <ao:prefix> to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E77E45D-0BB8-4168-8CAF-9D1591E37A36">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:11:50 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A1D65D6C-6A4B-478F-8140-AA87C27DB44D</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:A29DA787-54E3-4422-B166-2BA6676BC91D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CAC294B3-5790-4488-B65C-CB3269F765C6">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:16:30 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:366925ED-C6A8-41CA-97EB-602399B8DB72"/>
    <pav:lineageUri>urn:domeoserver:annotation:E7F026CF-6162-4445-A7F9-6B029DDC6F96</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9A220CC1-B0E4-46E3-92ED-BA102CB9A99F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D17A3686-1703-468A-9054-837449C245F1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E2F95CEA-24A5-407F-856C-8C142EEA5626"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9C5564E-F653-404D-B333-299E63141AF5">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D78CEABF-EE24-4AFF-81A9-B148050EFE16"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:228452B8-64FE-4746-AB80-952A986140F5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:15:52 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B5E4470-CD28-4DCB-9009-8377503D5E57">
    <pav:createdOn>2014-07-07 09:38:19 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:ACB2EB18-2590-4CF8-9CB3-0EF209C089E0"/>
    <pav:lineageUri>urn:domeoserver:annotation:E8807F31-F34F-4987-92C4-A2EE297A7A31</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:454E7688-A4B1-42BF-86B5-6E1A3C88986A">
    <pav:lineageUri>urn:domeoserver:annotation:B5E9E5D3-CEDE-43AC-A6D0-E7513DB65222</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 11:10:25 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:EEDA4663-FBED-4C68-848C-30943B88C061"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6F0B480-ABD4-436B-8A6F-A4BD34827F73">
    <ao:context rdf:resource="urn:domeoclient:uuid:30818391-5098-4A86-BF01-5AB0C0597335"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:945BD1E4-DE7D-4DBC-804B-A4E048F20780</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:11:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60E67B22-5DBF-4F42-9120-BC7E0F398FA0">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:B4D55559-EA4E-4B39-A156-D764B9CB8614</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-13 12:48:08 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nd8671dcd5b9c47b59c30819a64ee9dbb"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:AE5EBB85-C1D9-438F-B2E8-17B61D972F3D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N44d414c01129400d94b75e139631d034">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:697C8F03-1543-4427-9D85-7967FCEA3100">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D346F3FB-2896-495E-BF67-B2BC6E8F5714"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:41:30 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:E365599C-3650-4894-A315-9AFC760442EA</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D860A1B6-8D5E-4FE4-9EDB-4E1397B29BBD">
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3CE3E7D7-79CE-4BA9-8CA0-7B7A05D77AFC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:746D73EB-609F-4ABC-8FAC-F496DCDBACDA</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:38:04 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C901133-925A-4BA8-947F-0FE9FB6D60DB"/>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC9FB0B5-1564-4BF2-A4E4-4D05B0A1AB86">
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:37:19 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:4E623F19-61D3-4432-BDDE-28C77FBDA1C0</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F353BFC5-D6B5-4819-8EA8-0A44F2223E3B"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA2C0A64-143A-46D5-A408-01FC3EC62525">
    <pav:createdOn>2014-07-13 11:28:14 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:A65B00D7-6AC0-4BC7-B831-3E6D23520F80</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F4EA581-2F5C-4FF1-8DA3-D5101E760F69"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6EC654F2-7C5C-4C0B-9973-518245983B18">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:2B0A8F16-94F6-4911-8E78-98C4225AC672</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:36129C88-CE12-4AF2-ABDA-B2DC6006FD29"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:16:01 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A5707CC-D3AC-4807-9E98-6536CDC7AC55">
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 12:41:59 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:645C5A96-70FA-4A0B-86EC-B070C4FE123F</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:0DDFAFFA-5DE6-4D3B-BC30-6421E6531AD8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:420B9B73-0394-4975-8634-61202EA8F217">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:F0B97FA3-5873-4BED-A500-3F99EF51951C</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:83D060E5-70B4-4270-94D2-6FF812E77E78"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:12:03 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7FFFFE5E-7DBF-4B33-A8EC-B5E58DEE590D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:42:34 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A03AB529-B51D-495B-88D7-404C443338CF"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:1942C7AF-662B-419B-945F-EBC948BBC805</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C5594C9A-8B88-4CF6-B5AA-3F081580D92D">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:13:40 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8543469A-E725-45C1-A0A3-93FAB55D1DD5"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:3F11C6A1-A35B-4B78-8E4B-F4E54C9EB08B</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:77F990A5-C7A6-4873-A32F-AD9607EFDE51">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:10:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabol</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> occurred at about 1 hour. Peak concentrations of </ao:prefix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:77F990A5-C7A6-4873-A32F-AD9607EFDE51"/>
    <domeo:uuid>77F990A5-C7A6-4873-A32F-AD9607EFDE51</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA9BE1F2-854A-4E7D-8C64-DCE1158C5D96">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>AA9BE1F2-854A-4E7D-8C64-DCE1158C5D96</domeo:uuid>
    <pav:createdOn>2014-07-07 09:58:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Injection is predicted to provide a pharmacological effect of sildenafil and its </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>N</ao:exact>
    <ao:suffix>-</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AA9BE1F2-854A-4E7D-8C64-DCE1158C5D96"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2EC8E075-F7E3-4259-A656-99D292E9F0A4">
    <pav:lineageUri>urn:domeoserver:annotation:6A45E1E3-7270-4950-9185-AED9AF04A2E4</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:0124DF91-B793-47E7-9547-2BF080146FA7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:12:20 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3D2A83E-9B62-495D-A7E7-A17FEF5E2561">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>F3D2A83E-9B62-495D-A7E7-A17FEF5E2561</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>The mechanism of action of </ao:prefix>
    <pav:createdOn>2014-07-13 11:04:07 -0400</pav:createdOn>
    <ao:suffix>, as with other drugs used to treat schizophrenia, is unknown. However, it has been proposed that the drug’s therapeutic activity in schizophrenia is mediated through a combination of dopamine Type 2 (D2) and serotonin Type 2 (5HT2) receptor antagonism.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3D2A83E-9B62-495D-A7E7-A17FEF5E2561"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7907DD5-4FA4-4B5A-99D9-9D24B76931C6">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4A784235-A949-4FFD-9438-52955B529B7A</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1D92FA7B-3CB7-4C89-9E21-9980B649BC2E"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 11:22:37 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:441651E7-B4B0-4FA2-BDD8-3B5B7B207EE2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>type</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:34:22 -0400</pav:createdOn>
    <ao:suffix>-5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hypert</ao:suffix>
    <domeo:uuid>441651E7-B4B0-4FA2-BDD8-3B5B7B207EE2</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:441651E7-B4B0-4FA2-BDD8-3B5B7B207EE2"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFE95BF7-1349-414E-B68F-6C5149A03072">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 11:22:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>EFE95BF7-1349-414E-B68F-6C5149A03072</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>exposure without concomitant medication is shown to be 5-fold higher at a dose of 80 mg TID compared to its exposure at a dose of 20 mg </ao:prefix>
    <ao:exact>TID</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EFE95BF7-1349-414E-B68F-6C5149A03072"/>
    <ao:suffix>. This concentration range covers the same increased sildenafil exposure observed in specifically-designed drug interaction studies with CYP3A inhibitors (except for potent inhibitors such as ketoconazole, itraconazole, and ritonavir).</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2F70BCB-D9EC-44EA-93E7-C33A22842BF2">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 12:46:37 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:F4CD88A4-5CEC-433F-9DFF-C429C94CCEA2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:57242808-9748-4ED3-908E-E0054E0C8BBE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA4C8A6E-17D4-47F8-A369-67AF061E9037">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:544A607C-AF7D-4602-81E2-A48B9FFC5466</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A412DBFC-2FE0-43FA-A538-B84D822A5BFD"/>
    <pav:createdOn>2014-07-07 09:44:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49F8A244-9291-40F9-AE95-B64DDF5E624D">
    <domeo:uuid>49F8A244-9291-40F9-AE95-B64DDF5E624D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>metabolite</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:49F8A244-9291-40F9-AE95-B64DDF5E624D"/>
    <ao:suffix> are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:57:03 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0DCF362-11F8-4FF3-8C3C-EDB9DD3D53A7">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:206422C6-3F3C-47E8-AC4D-3CADF0982F38</pav:lineageUri>
    <pav:createdOn>2014-07-07 11:22:54 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:3A07EF3E-A1DF-4E0E-952B-5422EC6E9B3D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBE541BF-AED9-48E5-ACA0-9309C45B20F5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:12:09 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:133A11F3-97FE-4A36-97AB-CF474CA6CAA0</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:78BBB6BD-543C-42F3-B5F5-431ADE5F4D72"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D2E5F5D-2D44-4EC9-93CD-D558EE6CAD75">
    <domeo:uuid>3D2E5F5D-2D44-4EC9-93CD-D558EE6CAD75</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>to patients with pulmonary arterial hypertension, lesser reductions than above in systolic and diastolic blood pressures were observed (a decrease in both of 2 mmHg).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3D2E5F5D-2D44-4EC9-93CD-D558EE6CAD75"/>
    <pav:createdOn>2014-07-07 09:40:26 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb3430e02bd5144f98224ed9fcabd8669">
    <domeo:sets rdf:resource="urn:pddi:uuid:01E43715-3610-4176-8FB9-E2D7C94F6C63"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3805F006-2423-4B51-87AB-CAE85C6B4E21">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A95EA236-59E2-47FB-878A-81116D82930F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:4E13C50F-B8D6-4676-A219-AD5C04FF7CDB</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:10:15 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:11E26B74-9DE2-4B10-A8C9-A250D2747B3E">
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:74A8BD59-3770-4E00-8C04-C4D9A82E8F47</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 12:55:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:EBCFB082-4C3F-4C27-B1B4-7DE7E01178ED"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55E92945-9B4A-406D-8BFF-54471B2E432E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:17:02 -0400</pav:createdOn>
    <domeo:uuid>55E92945-9B4A-406D-8BFF-54471B2E432E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers. The apparent half-life of </ao:prefix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix> was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, were similar in extensive and poor metabolizers, wi</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:55E92945-9B4A-406D-8BFF-54471B2E432E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA7B78BE-B91C-4178-9AF1-7DC800EF5121">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:B08B644F-5630-4DD4-870A-83EE4BFF9279</pav:lineageUri>
    <pav:createdOn>2014-07-07 11:22:50 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5139C7C3-ACE5-4F03-BC84-8DD2AF187DDB"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12FA04F1-54A6-4C48-9FDA-8E372C8A648A">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 12:38:23 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A810EBBA-9C6C-4A0D-9FD2-AFA2874096F5"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:13CBA444-A83A-48E8-AC3C-79379FB9E6F7</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FD113AB-8FB6-4F29-B1BE-0A776992E0B0">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>5FD113AB-8FB6-4F29-B1BE-0A776992E0B0</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:39:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>TID sildenafil</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5FD113AB-8FB6-4F29-B1BE-0A776992E0B0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DDFAFFA-5DE6-4D3B-BC30-6421E6531AD8">
    <domeo:uuid>0DDFAFFA-5DE6-4D3B-BC30-6421E6531AD8</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:41:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Oral contraceptives were administered as a single dose both before and after the oral administration of fluconazole 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in ethinyl estradiol or </ao:prefix>
    <ao:suffix> AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>levonorgestrel</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0DDFAFFA-5DE6-4D3B-BC30-6421E6531AD8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD57239D-3225-4F0C-8054-FBD32976EE0C">
    <pav:createdOn>2014-07-13 11:17:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AD57239D-3225-4F0C-8054-FBD32976EE0C"/>
    <domeo:uuid>AD57239D-3225-4F0C-8054-FBD32976EE0C</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <ao:suffix> in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. Risperidone doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> in subjects with liver disease were comparable to those in young healthy subjects, the mean free fraction of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76D2A20E-E18E-4676-958D-12D182D20430">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B2317F54-7476-4D82-9C44-76D503E6DA71</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:37:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:575F0CD0-2CEC-4594-9019-B1A6C8BA5D55"/>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0645479-B3CA-4505-B451-B003C3B19554">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:EABDAFD6-3CCF-4D2C-BD80-C1DB3A591C0B</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:195005D8-3CE9-43AD-A3D8-56739DB440A4"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 12:44:25 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE16BF01-AD42-444E-9A68-FEF6AED26815">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E5D76E00-F5D9-4E93-B3B6-47859812ACDF"/>
    <pav:lineageUri>urn:domeoserver:annotation:09060B7A-6009-499B-A967-F99ED8CDF86B</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:39:36 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4CEC1749-9AA0-4FDA-B649-6B3CDED4298A">
    <ao:prefix> AUC and a significant increase in apparent oral clearance of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4CEC1749-9AA0-4FDA-B649-6B3CDED4298A"/>
    <pav:createdOn>2014-07-13 12:56:07 -0400</pav:createdOn>
    <domeo:uuid>4CEC1749-9AA0-4FDA-B649-6B3CDED4298A</domeo:uuid>
    <ao:suffix>. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTI</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F3CA373-B79A-4B2D-8C96-BFB67CB4B175">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:16:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:6784E1B8-4746-4B76-AE23-2ACB7CBA8ADF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:612855C1-32AF-48C7-A341-A649DD897808"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F97F910-5C88-42D5-BF36-6EFC8C9A3DD1">
    <ao:exact>When a single 100 mg dose of sildenafil was co-administered with erythromycin, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC)</ao:exact>
    <domeo:uuid>5F97F910-5C88-42D5-BF36-6EFC8C9A3DD1</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 11:35:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F97F910-5C88-42D5-BF36-6EFC8C9A3DD1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7CF0599-4EF7-4EA9-AA71-F3F0B7596EF6">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B7CF0599-4EF7-4EA9-AA71-F3F0B7596EF6"/>
    <pav:createdOn>2014-07-13 11:26:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B7CF0599-4EF7-4EA9-AA71-F3F0B7596EF6</domeo:uuid>
    <ao:exact>The mechanism of action of risperidone, as with other drugs used to treat schizophrenia, is unknown. However, it has been proposed that the drug’s therapeutic activity in schizophrenia is mediated through a combination of dopamine Type 2 (D2) and serotonin Type 2 (5HT2) receptor antagonism.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E52164F-6FEF-4A1A-A55B-01314BCEB19B">
    <domeo:uuid>7E52164F-6FEF-4A1A-A55B-01314BCEB19B</domeo:uuid>
    <ao:suffix>. Consequently, the clinical effect of the drug results from the combined concentrations of risperidone plus 9-hydroxyrisperidone.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7E52164F-6FEF-4A1A-A55B-01314BCEB19B"/>
    <ao:prefix>, has similar pharmacological activity as </ao:prefix>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:12:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:636BB7C2-294D-452D-967D-461DEF7A510A">
    <ao:exact>Risperidone</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:07:17 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:636BB7C2-294D-452D-967D-461DEF7A510A"/>
    <domeo:uuid>636BB7C2-294D-452D-967D-461DEF7A510A</domeo:uuid>
    <ao:suffix> is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. Risperidone acts as an antagonist at other receptors, but with</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76A2A466-4D5D-4AA1-8114-FAD1FF0E6FC0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>Cmax and a 210% increase in sildenafil AUC.</ao:suffix>
    <pav:createdOn>2014-07-07 11:24:12 -0400</pav:createdOn>
    <domeo:uuid>76A2A466-4D5D-4AA1-8114-FAD1FF0E6FC0</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76A2A466-4D5D-4AA1-8114-FAD1FF0E6FC0"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>(100 mg single dose) resulted in a 140% increase in </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0AC894E-27E2-43D9-BFEB-167E8117247A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>B0AC894E-27E2-43D9-BFEB-167E8117247A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sertraline</ao:exact>
    <ao:prefix> hydrochloride is supplied for oral administration as scored tablets containing </ao:prefix>
    <pav:createdOn>2014-07-13 12:34:38 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B0AC894E-27E2-43D9-BFEB-167E8117247A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <ao:suffix> hydrochloride equivalent to 25, 50, 100, 150 and 200 mg of sertraline and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABF527C0-D635-49E4-BC45-911EBB72D2E8">
    <domeo:uuid>ABF527C0-D635-49E4-BC45-911EBB72D2E8</domeo:uuid>
    <ao:suffix> is rapidly distributed. The volume of distribution is 1 to 2 L/kg. In plasma, risperidone is bound to albumin and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Nei</ao:suffix>
    <ao:exact>Risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Distribution: </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:10:47 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ABF527C0-D635-49E4-BC45-911EBB72D2E8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3238558-AF7F-4E81-BA1F-62B0266A4DDE">
    <pav:createdOn>2014-07-07 09:34:24 -0400</pav:createdOn>
    <domeo:uuid>E3238558-AF7F-4E81-BA1F-62B0266A4DDE</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hypertens</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>5 </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E3238558-AF7F-4E81-BA1F-62B0266A4DDE"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7561E693-ED7F-438D-97B3-6718EA0765EF">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:BA258499-09C3-45B8-8CA4-4B430E2DB5EB"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C9B2FC03-3B32-472D-B469-B9F86400F4C6">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>risperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7FE9AC63-C53E-4EF9-AEF0-CC1F82EDA7C3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/04F5EE18-51BD-4A42-A9E7-52826EE0EA8B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D860A1B6-8D5E-4FE4-9EDB-4E1397B29BBD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4E5EBBF-965D-41F8-B54E-0CF48653C43C">
    <pav:createdOn>2014-07-13 12:56:09 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:76B68D47-1D9C-4B2A-B9A6-CFE359C93E64"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:F61FAB34-A2B1-45CE-B6A6-123A03AAD69D</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E804A110-85A5-4650-B960-F11AB9FD25A2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> (10 mcg/mL), and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <pav:createdOn>2014-07-13 11:11:36 -0400</pav:createdOn>
    <domeo:uuid>E804A110-85A5-4650-B960-F11AB9FD25A2</domeo:uuid>
    <ao:exact>carbamazepine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E804A110-85A5-4650-B960-F11AB9FD25A2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:651C0626-4BF6-4B96-A66A-7385C6456D51">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:298F93DA-79DF-482C-B367-9A29F14FB3D6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:DD06894B-6765-494F-98ED-9B2C217D26FD"/>
    <pav:createdOn>2014-07-13 11:13:26 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:962DC691-3D08-4224-8D22-C0DD8D9F24CA">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:4EAFAB1D-1E62-4401-9065-8F44961694A1</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 12:56:00 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0F95BD67-87EE-4AA9-A33E-A0BCF7921FF0"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:575F0CD0-2CEC-4594-9019-B1A6C8BA5D55">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, </ao:prefix>
    <ao:suffix> dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>575F0CD0-2CEC-4594-9019-B1A6C8BA5D55</domeo:uuid>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:37:40 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:575F0CD0-2CEC-4594-9019-B1A6C8BA5D55"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F4851EA8-C391-4F16-B8F8-81A3F2688015">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fluconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90F5AA7B-F35E-4B00-A666-C6FE8F1B0324">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:FADFAA32-BB4A-4542-AEFD-2B7D80177234"/>
    <pav:lineageUri>urn:domeoserver:annotation:86034B03-551B-406A-BFE8-B44A1CB16857</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:10:35 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F557214F-193F-480C-8483-C59A8CFCD22E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F557214F-193F-480C-8483-C59A8CFCD22E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> is 70% (CV=25%). The relative oral bioavailability of </ao:prefix>
    <pav:createdOn>2014-07-13 11:09:17 -0400</pav:createdOn>
    <domeo:uuid>F557214F-193F-480C-8483-C59A8CFCD22E</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E72D7D03-AAE5-42A5-A83A-3C68C2C2BCB6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5A962BFF-E73B-4290-B642-C49A7EBCD1B8"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C9B2FC03-3B32-472D-B469-B9F86400F4C6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:539264FC-F626-408A-BB71-03BC387083CB">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:18:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:88B8196E-4906-4695-9420-CEEF74F91F98</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB311B8D-11CB-4B44-BDC1-9641D482BE0D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F63A36F-F819-4E40-9C8A-C518B5519787">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7F63A36F-F819-4E40-9C8A-C518B5519787</domeo:uuid>
    <ao:exact>albumin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and α1-acid glycoprotein. Risperidone doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <ao:prefix> in plasma was increased by about 35% because of the diminished concentration of both </ao:prefix>
    <pav:createdOn>2014-07-13 11:17:56 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F63A36F-F819-4E40-9C8A-C518B5519787"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4019A76A-1D16-4F04-8CBF-FF855DD2A7A2">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:07:17 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:09B51181-CF5C-416F-839B-FE6DF66105EA</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:636BB7C2-294D-452D-967D-461DEF7A510A"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD06894B-6765-494F-98ED-9B2C217D26FD">
    <domeo:uuid>DD06894B-6765-494F-98ED-9B2C217D26FD</domeo:uuid>
    <ao:prefix>m (about 6% to 8% of Caucasians, and a very low percentage of Asians, have little or no activity and are “poor metabolizers”) and to inhibition by a variety of substrates and some non-substrates, notably quinidine. Extensive CYP 2D6 metabolizers convert </ao:prefix>
    <pav:createdOn>2014-07-13 11:13:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> rapidly into 9-hydroxyrisperidone, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of rispe</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DD06894B-6765-494F-98ED-9B2C217D26FD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71CADA90-E1E5-4B50-9394-FDFC0B1512B0">
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 11:02:33 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <pav:lineageUri>urn:domeoserver:annotationset:BA49274C-11BD-499C-B6F3-8E9B55B40E77</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:390CA5FE-7939-4F69-B612-7F5C21A06481"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-4.txt.html</ao:annotatesResource>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <permissions:permissions rdf:nodeID="N2780f3fa7841478ab66f4c82cf054f59"/>
    <pav:createdOn>2014-07-13 11:02:05 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2780f3fa7841478ab66f4c82cf054f59">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N395247a7e1ed4e71aab5f30ea6f2d063">
    <domeo:sets rdf:resource="urn:pddi:uuid:0CE6C620-40B4-4E55-8185-8A319ECD6D71"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1230CFBE-6F41-4107-8D50-5F5A730D40C5">
    <pav:createdOn>2014-07-13 11:07:49 -0400</pav:createdOn>
    <ao:prefix> acts as an antagonist at other receptors, but with lower potency. </ao:prefix>
    <ao:exact>Risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>1230CFBE-6F41-4107-8D50-5F5A730D40C5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-sensitive sigma site, and no affinity (when tested at concentrations &gt;10-5 M) </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1230CFBE-6F41-4107-8D50-5F5A730D40C5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B6E9A08-C112-4656-8901-F8802CD64317">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 12:45:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2BF9F224-82C0-470E-9645-8A6965E66A04"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Ne6d6f44b868b4d9fbfa16a26d57ec715"/>
    <pav:lineageUri>urn:domeoserver:annotation:B0DBD770-879A-4A78-90BD-890A235DEC8D</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B088F7FA-8870-4336-965B-4A558E3F08B0">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 11:17:32 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:0D1F3FB5-E327-4ED5-A129-940CBC83C151</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:ABB70710-CA87-4445-8EB3-1BFDDC4636FE"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7950DCED-7411-4B59-B629-CB1341A53897">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7950DCED-7411-4B59-B629-CB1341A53897</domeo:uuid>
    <ao:suffix>on Blood Pressure</ao:suffix>
    <ao:exact>REVATIO </ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7950DCED-7411-4B59-B629-CB1341A53897"/>
    <pav:createdOn>2014-07-07 09:51:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Effects of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B18CF78-48CD-4D32-B4F4-88F8072C8185">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:E0ECD29D-DAB1-4D63-85F1-1839E3B04BF6"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A50036CB-D487-48AB-9CE3-45B6CA3540CD</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:11:19 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4EEAF739-3D04-465D-8AC0-35EAE4B00AE0">
    <pav:createdOn>2014-07-13 12:35:54 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:3D8D67C2-6E18-4F0E-AEDD-1DFCE48220A1</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3FEE8D2-9817-490A-AF14-CC53E5ADFBF2"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40519342-F06B-41D2-A39A-795BA218AF7B">
    <pav:createdOn>2014-07-13 12:46:18 -0400</pav:createdOn>
    <domeo:uuid>40519342-F06B-41D2-A39A-795BA218AF7B</domeo:uuid>
    <ao:exact>cimetidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:prefix> 400 mg to six healthy male volunteers. After the administration of </ao:prefix>
    <ao:suffix>, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:40519342-F06B-41D2-A39A-795BA218AF7B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA230F0A-406C-43AE-88DE-A7FD67CF4D61">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:EEA0DB9F-24A6-4283-B426-FDECA24BE603"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 11:12:34 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:814003AB-50EC-489D-967C-53D890293957</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86692ABC-62BE-4895-A4EF-50FCB21327B2">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. It would also be possible for </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:86692ABC-62BE-4895-A4EF-50FCB21327B2"/>
    <pav:createdOn>2014-07-13 11:16:08 -0400</pav:createdOn>
    <ao:suffix> to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>86692ABC-62BE-4895-A4EF-50FCB21327B2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3C4287B-36A9-48BF-8081-A39BEF5F3C51">
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:BB359BC3-6C0F-427E-B961-0838B54690D5"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:38:27 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:2CB15B00-6B57-4B22-8474-DB6365688798</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:952FDCF1-252C-42FC-BE9F-40622C26F85D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>952FDCF1-252C-42FC-BE9F-40622C26F85D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:952FDCF1-252C-42FC-BE9F-40622C26F85D"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>nitrates </ao:exact>
    <ao:suffix>[see Contraindications (4)].</ao:suffix>
    <pav:createdOn>2014-07-07 09:38:21 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9011E52E-6FAE-42BF-913B-D3EF952E8A2B">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:04:07 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3D2A83E-9B62-495D-A7E7-A17FEF5E2561"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:B9422143-55C7-4DC9-89FD-1C96FFB68383</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E17F3ACA-8486-4702-886B-6FA2562FDEFF">
    <ao:suffix> AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <ao:exact>levonorgestrel</ao:exact>
    <ao:prefix> AUC was 6% (range: -47 to 108%) and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E17F3ACA-8486-4702-886B-6FA2562FDEFF</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:44:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E17F3ACA-8486-4702-886B-6FA2562FDEFF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A3DCC3AB-4469-4227-B682-6E7F65CD2A7A">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9D2EDEBD-1223-4650-A96C-6AA36F00C854"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EAE26632-A8D8-4E80-ADE1-8902853460F6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:39:26 -0400</pav:createdOn>
    <ao:prefix>After chronic dosing of 80 mg </ao:prefix>
    <domeo:uuid>EAE26632-A8D8-4E80-ADE1-8902853460F6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:exact>TID </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EAE26632-A8D8-4E80-ADE1-8902853460F6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2BF9F224-82C0-470E-9645-8A6965E66A04">
    <ao:suffix> The mean increase in</ao:suffix>
    <domeo:uuid>2BF9F224-82C0-470E-9645-8A6965E66A04</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:45:35 -0400</pav:createdOn>
    <ao:exact>There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> 50 mg once daily for 10 days in 10 healthy women. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2BF9F224-82C0-470E-9645-8A6965E66A04"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E597BBC-9857-4D08-953B-5CBE831F5884">
    <pav:createdOn>2014-07-13 11:26:45 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B7CF0599-4EF7-4EA9-AA71-F3F0B7596EF6"/>
    <pav:lineageUri>urn:domeoserver:annotation:DE221D8D-564A-4ED6-8FA2-FEACF6BADD9F</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:body rdf:nodeID="N1d2fcb8abfd9458e9e6075fe42cbca0c"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8186AE14-85DE-4E1A-B5F4-BC58233DC47B">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:43E08535-8340-472C-92D9-100ECFA2CB93"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F14E8BB4-85EC-49A7-B9E5-8976B448D19D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>pharmacokinetics in patients with PAH. The dataset available for the population pharmacokinetic evaluation contained a wide range of demographic data and laboratory parameters associated with hepatic and renal function. None of these factors had a signif</ao:suffix>
    <domeo:uuid>F14E8BB4-85EC-49A7-B9E5-8976B448D19D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>Age, gender, race, and renal and hepatic function were included as factors assessed in the population pharmacokinetic model to evaluate </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 09:59:05 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F14E8BB4-85EC-49A7-B9E5-8976B448D19D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA839309-7C8B-4446-A5C1-08694E7B8482">
    <ao:exact>9-</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>, its major metabolite, </ao:prefix>
    <domeo:uuid>FA839309-7C8B-4446-A5C1-08694E7B8482</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FA839309-7C8B-4446-A5C1-08694E7B8482"/>
    <pav:createdOn>2014-07-13 11:09:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb25235f9e1a145a79bfdc2c872bf952b">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56F428F6-CAF7-4343-B57C-103B1BA935EB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:679C48F0-BCFA-4F3B-93B6-03B171A529E1</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:10:06 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:532294F2-A52D-4732-85C4-0F955156A615"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58C4B9F6-E8BB-4567-9FF2-3D87C6E9284C">
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>58C4B9F6-E8BB-4567-9FF2-3D87C6E9284C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:58C4B9F6-E8BB-4567-9FF2-3D87C6E9284C"/>
    <ao:exact>There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 12:45:51 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34472B29-EA4E-45E5-84B2-2EEE556610B6">
    <pav:lineageUri>urn:domeoserver:annotation:29BBE1A3-B55A-462F-A387-1BC5EE901EF7</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:B294F73B-169E-4106-90EF-3C87099953E8"/>
    <pav:createdOn>2014-07-13 11:29:18 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nfe9f8439115a43fdb3769fde786e7730"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/94DFD21D-D749-4F5E-AE57-CF5CE30BA0D9">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:799D7550-4333-4600-A69B-DE23093443A4">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F049BA4A-8DAF-49C1-ABA1-6E76A2F6DA6B"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N560bf5816a5d4547a5773f7a25fb99b9">
    <domeo:sets rdf:resource="urn:pddi:uuid:0605CFD4-BB68-443D-9ABF-C97A7A0563B0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14556CC1-0C55-47A6-8175-973C292639CC">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:16:08 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:71D2AAB3-67A2-451B-BC9A-B33DCA934E67</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:86692ABC-62BE-4895-A4EF-50FCB21327B2"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3EBDA2ED-165F-4B57-B4BE-CFA63CD5C5A6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:36:02 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>3EBDA2ED-165F-4B57-B4BE-CFA63CD5C5A6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Sildenafil</ao:exact>
    <ao:suffix>, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemi</ao:suffix>
    <ao:prefix>(PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3EBDA2ED-165F-4B57-B4BE-CFA63CD5C5A6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B951EF5-B48C-4B58-B273-480990730DEA">
    <ao:exact>quinidine</ao:exact>
    <pav:createdOn>2014-07-13 11:15:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>2B951EF5-B48C-4B58-B273-480990730DEA</domeo:uuid>
    <ao:suffix> have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., carbamazep</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B951EF5-B48C-4B58-B273-480990730DEA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> in patients receiving </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A31AAC0C-4709-458E-B722-42176D2F7E8D">
    <ao:prefix> concentrations than poor metabolizers, the pharmacokinetics of </ao:prefix>
    <ao:suffix> and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <pav:createdOn>2014-07-13 11:13:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A31AAC0C-4709-458E-B722-42176D2F7E8D"/>
    <domeo:uuid>A31AAC0C-4709-458E-B722-42176D2F7E8D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BB046B1-5949-4043-9525-70D01EC3816C">
    <ao:suffix> is bound to albumin and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> is rapidly distributed. The volume of distribution is 1 to 2 L/kg. In plasma, </ao:prefix>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:10:51 -0400</pav:createdOn>
    <domeo:uuid>9BB046B1-5949-4043-9525-70D01EC3816C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9BB046B1-5949-4043-9525-70D01EC3816C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EBCFB082-4C3F-4C27-B1B4-7DE7E01178ED">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Administration of a single oral 200 mg dose of </ao:prefix>
    <domeo:uuid>EBCFB082-4C3F-4C27-B1B4-7DE7E01178ED</domeo:uuid>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:55:59 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EBCFB082-4C3F-4C27-B1B4-7DE7E01178ED"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in flucon</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A05795B-B1AB-4DB3-A12F-2765CBCC2FED">
    <ao:item rdf:resource="urn:domeoclient:uuid:489FB94C-2475-4EC7-BE20-CF92749745A7"/>
    <pav:lineageUri>urn:domeoserver:annotationset:428337F8-4C91-47BA-A4E8-ABD1A86D1498</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 12:34:35 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:92530361-A562-40CE-942A-CC181EBE7AD7"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812eda990003"/>
    <permissions:permissions rdf:nodeID="N9d26768affa247bbbdcf2b8503c17652"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D3F1A48F-9525-4CA3-8022-C7885849CBC2"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-13 12:34:42 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8543469A-E725-45C1-A0A3-93FAB55D1DD5">
    <ao:suffix> concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <domeo:uuid>8543469A-E725-45C1-A0A3-93FAB55D1DD5</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8543469A-E725-45C1-A0A3-93FAB55D1DD5"/>
    <ao:prefix> and higher </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:13:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36129C88-CE12-4AF2-ABDA-B2DC6006FD29">
    <domeo:uuid>36129C88-CE12-4AF2-ABDA-B2DC6006FD29</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:16:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:36129C88-CE12-4AF2-ABDA-B2DC6006FD29"/>
    <ao:prefix> may cause a decrease in the combined plasma concentrations of </ao:prefix>
    <ao:suffix> and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5736B17-7DDF-4532-8056-6627EB5A439A">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:57129256-B2CA-4B2B-A838-B76DD1C015B3</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:952FDCF1-252C-42FC-BE9F-40622C26F85D"/>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:38:21 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E766D1AC-45BC-4579-89AD-BE0DEC69FC35">
    <pav:createdOn>2014-07-07 09:42:25 -0400</pav:createdOn>
    <ao:suffix>-</ao:suffix>
    <ao:exact>N</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>and its major circulating </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E766D1AC-45BC-4579-89AD-BE0DEC69FC35"/>
    <domeo:uuid>E766D1AC-45BC-4579-89AD-BE0DEC69FC35</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D92FA7B-3CB7-4C89-9E21-9980B649BC2E">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1D92FA7B-3CB7-4C89-9E21-9980B649BC2E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>clearance when it was co-administered with CYP3A inhibitors. Sildenafil exposure without concomitant medication is shown to be 5-fold higher at a dose of 80 mg TID compared to its exposure at a dose of 20 mg TID. This concentration range covers the same </ao:suffix>
    <domeo:uuid>1D92FA7B-3CB7-4C89-9E21-9980B649BC2E</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 11:22:37 -0400</pav:createdOn>
    <ao:prefix>Population data from patients in clinical trials indicated a reduction in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5A1F4E1-991C-4D93-AC6A-4DEDDF392601">
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 12:56:07 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:7920C548-5100-46DE-B19C-AFACF431A0C2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4CEC1749-9AA0-4FDA-B649-6B3CDED4298A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C446162-FA92-4715-9095-A116DC12F4C8">
    <pav:lineageUri>urn:domeoserver:annotation:22154A78-8E19-4B3A-8326-6AAAB8A19F14</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:15:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:B49DFB13-7D38-41A6-989C-F0F22BFBCA7D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97FF727B-70F7-4A8F-9355-6D53C2602A7E">
    <pav:createdOn>2014-07-13 11:13:47 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:A31AAC0C-4709-458E-B722-42176D2F7E8D"/>
    <pav:lineageUri>urn:domeoserver:annotation:7226510B-6369-4D4F-859D-276E6199315C</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B85AE85-A07C-4614-91F5-52EF7A4737DF">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:3E08DAB4-201F-48CD-8ACA-375750DA65B1"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:3BDF4B68-5BF9-4914-96AA-D5E7665E8769</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 11:22:56 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E221E79-602A-4812-8488-538D6506C879">
    <ao:context rdf:resource="urn:domeoclient:uuid:AD57239D-3225-4F0C-8054-FBD32976EE0C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:17:48 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:99FCA5E3-D174-4EE6-A00A-E8CEB0ED9FB4</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE5EBB85-C1D9-438F-B2E8-17B61D972F3D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> </ao:prefix>
    <ao:suffix> volunteers</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male</ao:exact>
    <pav:createdOn>2014-07-13 12:48:08 -0400</pav:createdOn>
    <domeo:uuid>AE5EBB85-C1D9-438F-B2E8-17B61D972F3D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AE5EBB85-C1D9-438F-B2E8-17B61D972F3D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B622988-60A1-49F1-966B-8460BBF1DD4D">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3967C16-EC04-423B-908A-CF2BC1EC4011"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:04:27 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:18FCF895-E37C-47DC-9D3E-92CD602023DD</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FD9D4BD5-A390-4CD6-8FF4-21ABE76D596A">
    <pav:lineageUri>urn:domeoserver:annotation:4B02B1E0-9F20-40AA-9E20-12AD253C4462</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB01A892-8D67-4A38-8CA4-2D230875A1F6"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 11:17:12 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3A07EF3E-A1DF-4E0E-952B-5422EC6E9B3D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 11:22:54 -0400</pav:createdOn>
    <ao:prefix>(800 mg), a nonspecific CYP inhibitor, caused a 56% increase in plasma </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>concentrations when co-administered with sildenafil (50 mg) to healthy volunteers.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>3A07EF3E-A1DF-4E0E-952B-5422EC6E9B3D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3A07EF3E-A1DF-4E0E-952B-5422EC6E9B3D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70B9E8E9-06ED-4420-9CDE-4E0F36F57CC9">
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix> combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:70B9E8E9-06ED-4420-9CDE-4E0F36F57CC9"/>
    <pav:createdOn>2014-07-13 11:17:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>70B9E8E9-06ED-4420-9CDE-4E0F36F57CC9</domeo:uuid>
    <ao:prefix> and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0E54D90-28C4-48FD-B72C-21011511DD58">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:CC36BBDD-6E14-44E8-9E21-FE419782FE72</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 12:45:51 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nb49daa32b1b24910b2b0b9300c519f04"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:58C4B9F6-E8BB-4567-9FF2-3D87C6E9284C"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DDA4ED5-743F-4C12-93A8-37B2366FF364">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:17:38 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:135F1FE6-83FC-4E58-95A7-4C08AED291BA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:341C8689-0903-4B8F-836F-B52DFF733FFD</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F95BD67-87EE-4AA9-A33E-A0BCF7921FF0">
    <domeo:uuid>0F95BD67-87EE-4AA9-A33E-A0BCF7921FF0</domeo:uuid>
    <pav:createdOn>2014-07-13 12:56:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> after 15 days of </ao:prefix>
    <ao:suffix> administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (ran</ao:suffix>
    <ao:exact>rifampin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0F95BD67-87EE-4AA9-A33E-A0BCF7921FF0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:010AF63D-C71E-4A93-9F41-8E5764F068ED">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 12:45:54 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:451E9FBF-CD25-4B95-963D-2A293790A1B4</pav:lineageUri>
    <pav:createdOn>2014-07-13 12:42:05 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:00CDF4D6-2271-4B2A-9836-98BD00E7E952"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:23567EF7-7482-444A-B1F6-5AAA9D43E54A</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D7F3CF4B-F577-4BF7-B88B-B5D04D01A04A">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9A220CC1-B0E4-46E3-92ED-BA102CB9A99F"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F63AE259-E4D8-48C8-9143-FADBBFAD548B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-sensitive sigma site, and no affinity (when tested at concentrations &gt;10-5 M) for cholinergic muscarinic or β1 and β2 adrenergic receptors.</ao:suffix>
    <domeo:uuid>F63AE259-E4D8-48C8-9143-FADBBFAD548B</domeo:uuid>
    <ao:prefix> has low to moderate affinity (Ki of 47 to 253 nM) for the </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:07:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F63AE259-E4D8-48C8-9143-FADBBFAD548B"/>
    <ao:exact>serotonin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:017A9836-D985-4347-BFF0-9EBED8DB5CD1">
    <pav:createdOn>2014-07-13 11:17:02 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:55E92945-9B4A-406D-8BFF-54471B2E432E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:489A8473-952A-4034-A912-302A2847F038</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CE1B6F16-57BD-40EB-AB83-B1A40576F8C0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23E5F3F5-E089-460E-A736-58E2FC44ADC6">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C84DD53D-5B64-47C5-92EE-E2D0E78BD754"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:11:55 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:8FDCFCF8-1579-4EA3-B0D9-73159007B108</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8214D15C-5AF1-47D0-A63C-30543353403D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>8214D15C-5AF1-47D0-A63C-30543353403D</domeo:uuid>
    <ao:prefix> dosing resulted in small increases in the mean AUCs of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8214D15C-5AF1-47D0-A63C-30543353403D"/>
    <ao:suffix> and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cau</ao:suffix>
    <ao:exact>ethinyl estradiol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 12:37:44 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DC200567-4E8F-495B-9D13-A2A04A7A47EC">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F1504F1A-B189-4B6A-9973-4A17775240C5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/83E9958D-5BAA-415C-B14A-C204CC3ED68C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0991F050-6152-45E8-8D40-DC901E368C9E">
    <ao:suffix> and its active metabolite decreased by 60% compared to young healthy subjects. Risperidone doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:17:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>Renal Impairment: In patients with moderate to severe renal disease, clearance of the sum of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0991F050-6152-45E8-8D40-DC901E368C9E</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0991F050-6152-45E8-8D40-DC901E368C9E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B98C3482-C44D-4C61-ACC3-D277890BCE91">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B98C3482-C44D-4C61-ACC3-D277890BCE91"/>
    <domeo:uuid>B98C3482-C44D-4C61-ACC3-D277890BCE91</domeo:uuid>
    <pav:createdOn>2014-07-07 11:23:25 -0400</pav:createdOn>
    <ao:exact>REVATIO </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>Injection: Predictions based on a pharmacokinetic model suggest that drug-drug interactions with CYP3A inhibitors will be less than those observed after oral sildenafil administration.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:371BCC12-3242-4854-9882-2DB2B2EE1A70">
    <pav:createdOn>2014-07-13 12:38:53 -0400</pav:createdOn>
    <ao:prefix> AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of </ao:prefix>
    <ao:exact>norethindrone</ao:exact>
    <domeo:uuid>371BCC12-3242-4854-9882-2DB2B2EE1A70</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:suffix> decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatment.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:371BCC12-3242-4854-9882-2DB2B2EE1A70"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:806597EC-5BAB-46E0-96D6-B25563A80A8C">
    <ao:exact>risperidone</ao:exact>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:14:57 -0400</pav:createdOn>
    <domeo:uuid>806597EC-5BAB-46E0-96D6-B25563A80A8C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:806597EC-5BAB-46E0-96D6-B25563A80A8C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBB863B4-0141-4362-8357-0FD5A3909A10">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:098AA784-6695-4935-9450-C87D502EDBCD"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:23:07 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:23A67AAE-576A-4FB5-8468-E2C34B2748CB</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFBA3663-4C52-45BA-895B-7EB3C0A4DA3A">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:03C6457D-A506-405A-9290-D5818D79A053</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:11:43 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:1B4D9B85-636E-45EE-9796-1A7AE7E45DCF"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3C500E90-E946-4B1B-B3D2-27B11967A625">
    <ao:context rdf:resource="urn:domeoclient:uuid:441651E7-B4B0-4FA2-BDD8-3B5B7B207EE2"/>
    <pav:createdOn>2014-07-07 09:34:22 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:62EDA0C1-785C-4EA5-8DB3-7CC59013D2D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05BFBD66-D24D-4F61-89C5-4EDDE7B6040C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:CA7C94FF-7470-4B26-A1E1-5C8247C8F0FC</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:10:51 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:9BB046B1-5949-4043-9525-70D01EC3816C"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/851B37FE-C029-42CD-9AFE-2CD0906FA393">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28EA3105-DAE4-4248-8C5A-EACDF44B4680">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ECG </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>28EA3105-DAE4-4248-8C5A-EACDF44B4680</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>were reported.</ao:suffix>
    <pav:createdOn>2014-07-07 09:39:29 -0400</pav:createdOn>
    <ao:prefix>to patients with pulmonary arterial hypertension, no clinically relevant effects on </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:28EA3105-DAE4-4248-8C5A-EACDF44B4680"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:532294F2-A52D-4732-85C4-0F955156A615">
    <domeo:uuid>532294F2-A52D-4732-85C4-0F955156A615</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:10:06 -0400</pav:createdOn>
    <ao:prefix> plus </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:532294F2-A52D-4732-85C4-0F955156A615"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour. Peak concentrations of 9-hydroxyrisp</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B6D964C-5C7B-4A8B-91D1-71E48BED6297">
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 12:46:12 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:A5674909-9644-497C-B284-D55E831FC413</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D16208CB-7392-415A-8487-52928A419F00"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A46A827E-4936-4BBC-8078-913DD6DAA84E">
    <pav:createdOn>2014-07-13 11:14:00 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC8C2FEA-C8BE-4A4F-98E3-3E4C44B65C83"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5B70F474-288C-4C1B-AF18-E0EF9B5EE27B</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3F1A48F-9525-4CA3-8022-C7885849CBC2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 12:34:42 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 12:34:41 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:0EB4AE1F-6DB3-497B-AAE0-DD8E03C51D30</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:4FCA7E7B-CC82-4455-94C0-73C09ED070C1"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:6A05795B-B1AB-4DB3-A12F-2765CBCC2FED</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4441B5B-C18F-4F66-90A8-3A3306CD1C90">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 09:42:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>desmethyl </ao:exact>
    <ao:prefix>and its major circulating N-</ao:prefix>
    <domeo:uuid>C4441B5B-C18F-4F66-90A8-3A3306CD1C90</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C4441B5B-C18F-4F66-90A8-3A3306CD1C90"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5A962BFF-E73B-4290-B642-C49A7EBCD1B8">
    <rdfs:label>serotonin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/1311214</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F46BEE2C-B82E-4386-96D7-C74221898C04">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:90D2913F-1AFA-432E-968A-2D879173B288</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B951EF5-B48C-4B58-B273-480990730DEA"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 11:15:12 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEC761C8-1050-4E1A-A450-D460F8514160">
    <pav:createdOn>2014-07-13 11:18:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:FE75629E-FE6A-4361-BE28-79148B042D27</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:984E4D2D-A998-4068-9BF7-F709348DD1B2"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FF2B43E-5E15-4C21-BFDD-C97D4C18B3B1">
    <ao:context rdf:resource="urn:domeoclient:uuid:C2EEFE36-AE7E-4BF4-943E-03D2760C673E"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:08:45 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:28D6D7F6-0FFB-41F2-BC7C-A9F0E4ED53AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72584FCC-E5F1-4130-993B-ED469AE3E810">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:4F012046-527A-4412-B5FE-F766182124E4</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5B7BF8E5-F410-48B2-AF56-5421E6B7FF0B"/>
    <pav:createdOn>2014-07-13 11:15:50 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92DB5361-BE2B-4C69-B141-FB431E8EFC22">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:17:24 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:BF0C3C69-52C2-4462-9A48-708B80A1A097</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:0991F050-6152-45E8-8D40-DC901E368C9E"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16393981-08BF-477D-ACB9-8FB804E50D0C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:57:03 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:49F8A244-9291-40F9-AE95-B64DDF5E624D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:5D5E7705-CD13-417B-BE4C-010E6D19EB36</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 10:02:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF657FF8-3529-4A9B-9294-13C604834E0A">
    <pav:lineageUri>urn:domeoserver:annotation:AB1C3D00-CC4C-4CA3-B347-69BA6BFE0FBF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 12:56:54 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-13 12:56:57 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:211F5FD6-FC29-4AC5-96E1-14E088108ABB"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E89548FF-A4A2-4B87-B1E1-B12E3E255FA1</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N511a9ab417244d2eba8f728ae193e85e"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:553A6608-733A-477E-BDCB-F0D16F1054E3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E4072F00-AC18-479B-BBF5-FE87E12CA45B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/093D1F2A-587E-4B3C-AAF4-10347561D8A9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0CCA954-EB0E-4D16-9B00-C1E4BE4A989D">
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0CCA954-EB0E-4D16-9B00-C1E4BE4A989D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 11:24:14 -0400</pav:createdOn>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>F0CCA954-EB0E-4D16-9B00-C1E4BE4A989D</domeo:uuid>
    <ao:prefix>Cmax and a 210% increase in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>AUC.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AEC296E5-554D-42F1-BF6A-CA09B038958F">
    <ao:suffix>to healthy volunteers, the largest mean change from baseline in supine systolic and supine diastolic blood pressures was a decrease of 9.0 mmHg and 8.4 mmHg, respectively.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AEC296E5-554D-42F1-BF6A-CA09B038958F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>After chronic dosing of 80 mg TID </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>AEC296E5-554D-42F1-BF6A-CA09B038958F</domeo:uuid>
    <pav:createdOn>2014-07-07 09:39:24 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35CE9A7F-F23D-4EBE-B09F-02A153717FBA">
    <ao:suffix> can be given with or without meals.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:10:38 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid>35CE9A7F-F23D-4EBE-B09F-02A153717FBA</domeo:uuid>
    <ao:prefix>. Thus, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:35CE9A7F-F23D-4EBE-B09F-02A153717FBA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5BA6BC8B-1F30-4288-9D03-060F552BAA12">
    <pav:createdOn>2014-07-13 11:16:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:DDA9B5AE-040F-439A-82F9-BF46844F39FC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:1BF82CCC-CD60-4AB5-8C1B-4176DC1A85F3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:76B24ED1-159D-4411-BD4C-8033557FAD2B">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DCA0957A-745E-4232-BE6B-45104AD0FFCD"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FCA7E7B-CC82-4455-94C0-73C09ED070C1">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:34:41 -0400</pav:createdOn>
    <ao:prefix> hydrochloride equivalent to 25, 50, 100, 150 and 200 mg of </ao:prefix>
    <ao:suffix> and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium starch glycolate, talc, and titanium dioxide.</ao:suffix>
    <ao:exact>sertraline</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>4FCA7E7B-CC82-4455-94C0-73C09ED070C1</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4FCA7E7B-CC82-4455-94C0-73C09ED070C1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F353BFC5-D6B5-4819-8EA8-0A44F2223E3B">
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>F353BFC5-D6B5-4819-8EA8-0A44F2223E3B</domeo:uuid>
    <ao:suffix>may be the basis for the enhanced platelet anti-aggregatory activity of nitric oxide observed in vitro, and the mild peripheral arterial-venous dilatation in vivo.</ao:suffix>
    <pav:createdOn>2014-07-07 09:37:19 -0400</pav:createdOn>
    <ao:prefix>In addition to pulmonary vascular smooth muscle and the corpus cavernosum, PDE5 is also found in other tissues including vascular and visceral smooth muscle and in platelets. The inhibition of PDE5 in these tissues by </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F353BFC5-D6B5-4819-8EA8-0A44F2223E3B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1085914C-2530-49EB-92B4-1E4BC17AEBAC">
    <ao:exact>acebutolol</ao:exact>
    <domeo:uuid>1085914C-2530-49EB-92B4-1E4BC17AEBAC</domeo:uuid>
    <pav:createdOn>2014-07-13 11:02:05 -0400</pav:createdOn>
    <ao:prefix>The usual initial dosage of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1085914C-2530-49EB-92B4-1E4BC17AEBAC"/>
    <ao:suffix> is 400 mg daily given as 200 mg b.i.d. Dosage should be increased gradually until an optimal clinical response is obtained, generally at 600 to 1200 mg per day. If treatment is to be discontinued, the dosage should be reduced gradually over a period of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-4.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3737933-330F-487F-B41C-CDB0FF5C6F1C">
    <ao:exact>metabolite </ao:exact>
    <domeo:uuid>D3737933-330F-487F-B41C-CDB0FF5C6F1C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>equivalent to that of a 20 mg oral dose.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D3737933-330F-487F-B41C-CDB0FF5C6F1C"/>
    <pav:createdOn>2014-07-07 09:58:59 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:43E08535-8340-472C-92D9-100ECFA2CB93">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AFDFD2C0-7545-4E19-ABAA-7E48CFD82223"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CE1B6F16-57BD-40EB-AB83-B1A40576F8C0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:167FB68A-5943-4F0E-8CC6-C6BAB7625E4F">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 12:38:47 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 12:41:10 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A6AB8619-AAFD-4D65-8839-376407154A96</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F5A4FF79-C22B-475D-8775-B7CA929DA67C"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4F872953-6D19-4809-9285-FCCF2FF54315</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:735CA4BD-A16D-4729-BFC3-96D72BFE5B0B">
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:996DAC66-98E7-4BAE-90CA-B2474D43F8E1</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:007F6835-1CAF-4F0B-8BFD-311D8BFD8926"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-07 11:23:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E8B9127A-D513-4699-BEA0-07E095BADF5D">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:29BA1C64-71E4-4437-B3E3-C16FF494B3CA"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:584394EB-71B4-485C-B5DE-CECED70A1339">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:E3238558-AF7F-4E81-BA1F-62B0266A4DDE"/>
    <pav:createdOn>2014-07-07 09:34:24 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:8CAC7CC1-905D-4DEF-889B-C73183EBC16C</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:114406CD-55D0-459D-A4F0-CEDB09E201C6">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7CBD8092-1453-4994-9F29-22622E743A15"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb1684bf5377b45158d6824adb5dc9100">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E76B5D64-7248-4EBD-A023-3820BFDEFD26">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C0F812BF-119E-4BE1-AAA3-BF2DAE39B76F"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:36:31 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:812DC48C-1B54-46F9-A56A-190D7D91EE6E</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AF0B949-C133-4703-9F65-362D4B5B4494">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6887274E-F614-42FD-904F-B7E202949297"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C0DB2807-8137-4A89-A166-930A58544F71</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:11:10 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:518CD4C6-1719-48AB-B300-84A10DEACB68">
    <pav:lineageUri>urn:domeoserver:annotation:01596A5C-8D3C-4B38-BEFB-CD0AFC09802B</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:35CE9A7F-F23D-4EBE-B09F-02A153717FBA"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:10:38 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3654752-C204-49F0-B3F7-87C2EE277992">
    <domeo:uuid>A3654752-C204-49F0-B3F7-87C2EE277992</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>serotonin</ao:exact>
    <ao:suffix> Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. Risperidone acts as an antagonist at other receptors, but with lower potency. Risperidone has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1</ao:suffix>
    <pav:createdOn>2014-07-13 11:07:24 -0400</pav:createdOn>
    <ao:prefix> is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A3654752-C204-49F0-B3F7-87C2EE277992"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FADFAA32-BB4A-4542-AEFD-2B7D80177234">
    <pav:createdOn>2014-07-13 11:10:35 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FADFAA32-BB4A-4542-AEFD-2B7D80177234"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>FADFAA32-BB4A-4542-AEFD-2B7D80177234</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Food Effect: Food does not affect either the rate or extent of absorption of </ao:prefix>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. Thus, risperidone can be given with or without meals.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:29BA1C64-71E4-4437-B3E3-C16FF494B3CA">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5AC4FDB3-99BB-4CC2-9A03-87893DB04756"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F4851EA8-C391-4F16-B8F8-81A3F2688015"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A268B82-4B69-4D00-A6E9-95F225012877">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A268B82-4B69-4D00-A6E9-95F225012877"/>
    <ao:prefix> to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>4A268B82-4B69-4D00-A6E9-95F225012877</domeo:uuid>
    <pav:createdOn>2014-07-13 11:16:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9aba69a11243475fad98519abd892ac5">
    <domeo:sets rdf:resource="urn:pddi:uuid:9B027AFC-3BAE-4FDC-889F-813F2AD35C5A"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/964F2661-87EF-4D00-87C8-D1C5E12C0ECB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5A4FF79-C22B-475D-8775-B7CA929DA67C">
    <domeo:uuid>F5A4FF79-C22B-475D-8775-B7CA929DA67C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 12:38:47 -0400</pav:createdOn>
    <ao:prefix> treatment did not cause a decrease in the </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F5A4FF79-C22B-475D-8775-B7CA929DA67C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ethinyl estradiol</ao:exact>
    <ao:suffix> AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatment.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DBBBE91C-3E2F-469A-9254-58328E372FEA">
    <ao:suffix>100 mg administered to healthy volunteers produced decreases in supine blood pressure (mean maximum decrease in systolic/diastolic blood pressure of 8/5 mmHg). The decrease in blood pressure was most notable approximately 1–2 hours after dosing, and was </ao:suffix>
    <ao:exact>sildenafil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DBBBE91C-3E2F-469A-9254-58328E372FEA"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>DBBBE91C-3E2F-469A-9254-58328E372FEA</domeo:uuid>
    <pav:createdOn>2014-07-07 09:37:41 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Single oral doses of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:01E43715-3610-4176-8FB9-E2D7C94F6C63">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:181381FE-800A-4970-81D8-2B14B7735770"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:person:uuid:080e143046812afe0146812eda990003">
    <foafx:title>nonexpert2</foafx:title>
    <foafx:middlename></foafx:middlename>
    <foafx:picture>http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg</foafx:picture>
    <foafx:homepage></foafx:homepage>
    <foafx:lastname>2</foafx:lastname>
    <foafx:name>nonexpert2</foafx:name>
    <foafx:firstname>nonexpert</foafx:firstname>
    <foafx:email>nonexpert2@gmail.com</foafx:email>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    <rdfs:label>nonexpert2</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:135F1FE6-83FC-4E58-95A7-4C08AED291BA">
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid>135F1FE6-83FC-4E58-95A7-4C08AED291BA</domeo:uuid>
    <ao:prefix>Hepatic Impairment: While the pharmacokinetics of </ao:prefix>
    <ao:suffix> in subjects with liver disease were comparable to those in young healthy subjects, the mean free fraction of risperidone in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. Risperidone d</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:135F1FE6-83FC-4E58-95A7-4C08AED291BA"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:17:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:181381FE-800A-4970-81D8-2B14B7735770">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BAE41BF7-CAA3-4865-832D-24EB9699E14C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8FE58707-AFDD-4F32-9EA8-03EC3BF4D67B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B7BF8E5-F410-48B2-AF56-5421E6B7FF0B">
    <ao:prefix> do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>5B7BF8E5-F410-48B2-AF56-5421E6B7FF0B</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5B7BF8E5-F410-48B2-AF56-5421E6B7FF0B"/>
    <pav:createdOn>2014-07-13 11:15:50 -0400</pav:createdOn>
    <ao:suffix>, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolis</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>carbamazepine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8680340-7715-4656-A160-A6F608AD7CE9">
    <pav:lineageUri>urn:domeoserver:annotation:9F72602C-A51D-443A-8FED-EF0310ADB89F</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F31EE1EC-A22F-4FE9-8763-7C623AD7B0BE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:08:54 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16FE2F0D-3BF4-4708-9147-BD5159B47059">
    <pav:createdOn>2014-07-13 11:14:31 -0400</pav:createdOn>
    <ao:suffix>. Extensive CYP 2D6 metabolizers convert </ao:suffix>
    <domeo:uuid>16FE2F0D-3BF4-4708-9147-BD5159B47059</domeo:uuid>
    <ao:exact>quinidine</ao:exact>
    <ao:prefix>r drugs. CYP 2D6 is subject to genetic polymorphism (about 6% to 8% of Caucasians, and a very low percentage of Asians, have little or no activity and are “poor metabolizers”) and to inhibition by a variety of substrates and some non-substrates, notably </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16FE2F0D-3BF4-4708-9147-BD5159B47059"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E202AAE6-7DCA-486D-9C29-8CB3B82CFECF">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:30903A1B-437C-4ABA-B24D-6148F07F178D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:70E60126-522D-4A50-BCBB-D49738745AFC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:09:35 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C2EEFE36-AE7E-4BF4-943E-03D2760C673E">
    <ao:suffix> results from the combined concentrations of risperidone and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:08:45 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>The clinical effect from </ao:prefix>
    <domeo:uuid>C2EEFE36-AE7E-4BF4-943E-03D2760C673E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C2EEFE36-AE7E-4BF4-943E-03D2760C673E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABB70710-CA87-4445-8EB3-1BFDDC4636FE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <ao:prefix> and its active metabolite decreased by 60% compared to young healthy subjects. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ABB70710-CA87-4445-8EB3-1BFDDC4636FE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>ABB70710-CA87-4445-8EB3-1BFDDC4636FE</domeo:uuid>
    <ao:exact>Risperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:17:32 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D318A30A-F708-43F6-AB5B-A9D659E063BF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ED3BCC98-B0FE-4421-B54B-7B2414CF4328"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/851B37FE-C029-42CD-9AFE-2CD0906FA393"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9D2EDEBD-1223-4650-A96C-6AA36F00C854">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/964F2661-87EF-4D00-87C8-D1C5E12C0ECB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7C1B3FD3-CA8D-4D2F-B094-F0DB74BF2108"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E728D92E-FEA6-4EE6-9E40-E59051DEB8E3">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:DDCD9620-FC48-419B-ACE3-537915C7889C</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 11:09:21 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:043FCC7B-7CBD-4BE5-9962-3F6CF2B132DB"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9d26768affa247bbbdcf2b8503c17652">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1A7382E8-45D1-4872-98EA-20455089A06B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 11:23:45 -0400</pav:createdOn>
    <ao:exact>saquinavir</ao:exact>
    <ao:suffix>, a CYP3A inhibitor, at steady state (1200 mg TID) with sildenafil (100 mg single dose) resulted in a 140% increase in sildenafil Cmax and a 210% increase in sildenafil AUC.</ao:suffix>
    <domeo:uuid>1A7382E8-45D1-4872-98EA-20455089A06B</domeo:uuid>
    <ao:prefix>In a study performed in healthy volunteers, co-administration of the HIV protease inhibitor </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1A7382E8-45D1-4872-98EA-20455089A06B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1BF82CCC-CD60-4AB5-8C1B-4176DC1A85F3">
    <ao:suffix> was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers. The apparent half-life of 9-hydroxyrisperidone was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinet</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1BF82CCC-CD60-4AB5-8C1B-4176DC1A85F3"/>
    <pav:createdOn>2014-07-13 11:16:53 -0400</pav:createdOn>
    <ao:prefix>The apparent half-life of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>1BF82CCC-CD60-4AB5-8C1B-4176DC1A85F3</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D17A3686-1703-468A-9054-837449C245F1">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdfs:label>cimetidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3967C16-EC04-423B-908A-CF2BC1EC4011">
    <ao:suffix> Type 2 (5HT2) receptor antagonism.</ao:suffix>
    <ao:prefix> Type 2 (D2) and </ao:prefix>
    <ao:exact>serotonin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:04:27 -0400</pav:createdOn>
    <domeo:uuid>F3967C16-EC04-423B-908A-CF2BC1EC4011</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3967C16-EC04-423B-908A-CF2BC1EC4011"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3FEE8D2-9817-490A-AF14-CC53E5ADFBF2">
    <pav:createdOn>2014-07-13 12:35:54 -0400</pav:createdOn>
    <ao:suffix> 300 mg to 21 normal females taking an oral contraceptive containing ethinyl estradiol and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, flucona</ao:suffix>
    <ao:prefix>A third study evaluated the potential interaction of once weekly dosing of </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
    <domeo:uuid>F3FEE8D2-9817-490A-AF14-CC53E5ADFBF2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3FEE8D2-9817-490A-AF14-CC53E5ADFBF2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C02BE13-5688-4657-A7A7-6A459283AEB2">
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1554FCFD-7477-413C-879A-913DFFAB5886"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:A431D5CB-5994-440B-99C7-32C2F2EC8DE9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:24:07 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 11:24:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6ECE2E9A-54C4-4507-95A6-2F4053719529">
    <pav:lineageUri>urn:domeoserver:annotation:D829A856-ADE0-4E82-B940-6DE74589EFC8</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:CF873305-5222-4D37-9C71-925D3C390B7A"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:09:51 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5672F5D0-071A-4DE9-9A98-BD20431A00C2">
    <ao:suffix>is an inhibitor of cGMP specific phosphodiesterase type-5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells res</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>5672F5D0-071A-4DE9-9A98-BD20431A00C2</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5672F5D0-071A-4DE9-9A98-BD20431A00C2"/>
    <pav:createdOn>2014-07-07 09:34:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Sildenafil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C4061A3-979D-486B-9CDA-1CFF771CCB5B">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:10:47 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:ABF527C0-D635-49E4-BC45-911EBB72D2E8"/>
    <pav:lineageUri>urn:domeoserver:annotation:67C400B9-D19B-4746-9FE2-12A58EE79507</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2537CEFB-4053-4AC9-8731-C65B1AC5D0F9">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:F1E65BAF-B906-4702-93F2-2AB99EAC8EC2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 11:15:55 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:D526C276-CAAE-4E9B-8038-08BB2FB8FBBD"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76258D2D-1630-4254-82ED-C3434163EAE3">
    <domeo:uuid>76258D2D-1630-4254-82ED-C3434163EAE3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 11:15:09 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <ao:suffix> in patients receiving quinidine have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known e</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76258D2D-1630-4254-82ED-C3434163EAE3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65044E3B-BE66-455E-B576-1B8DF996B6B4">
    <ao:prefix>, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>65044E3B-BE66-455E-B576-1B8DF996B6B4</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:13:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:65044E3B-BE66-455E-B576-1B8DF996B6B4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46780EA4-462F-4B55-AB22-23CB7FC82C80">
    <ao:prefix> oral solution is bioequivalent to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>46780EA4-462F-4B55-AB22-23CB7FC82C80</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:46780EA4-462F-4B55-AB22-23CB7FC82C80"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:09:25 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> tablets.</ao:suffix>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A1560B5F-D6E1-47EC-A088-C0C90A150994">
    <domeo:uuid>A1560B5F-D6E1-47EC-A088-C0C90A150994</domeo:uuid>
    <pav:createdOn>2014-07-07 09:42:27 -0400</pav:createdOn>
    <ao:exact>-</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A1560B5F-D6E1-47EC-A088-C0C90A150994"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83D060E5-70B4-4270-94D2-6FF812E77E78">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 11:12:03 -0400</pav:createdOn>
    <ao:prefix> is extensively metabolized in the liver. The main metabolic pathway is through hydroxylation of </ao:prefix>
    <ao:suffix> to 9-hydroxyrisperidone by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results fr</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:83D060E5-70B4-4270-94D2-6FF812E77E78"/>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>83D060E5-70B4-4270-94D2-6FF812E77E78</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB3EAD78-45A5-439B-B26A-FE0BB9EDCBD0">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:exact>Fluconazole</ao:exact>
    <pav:createdOn>2014-07-13 12:56:13 -0400</pav:createdOn>
    <ao:suffix> half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <domeo:uuid>AB3EAD78-45A5-439B-B26A-FE0BB9EDCBD0</domeo:uuid>
    <ao:prefix> increased 32% ± 17% (range: 16 to 72%). </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB3EAD78-45A5-439B-B26A-FE0BB9EDCBD0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/04F5EE18-51BD-4A42-A9E7-52826EE0EA8B">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/83395</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>saquinavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C84DD53D-5B64-47C5-92EE-E2D0E78BD754">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C84DD53D-5B64-47C5-92EE-E2D0E78BD754"/>
    <ao:suffix> is extensively metabolized in the liver. The main metabolic pathway is through hydroxylation of risperidone to 9-hydroxyrisperidone by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, h</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Risperidone</ao:exact>
    <pav:createdOn>2014-07-13 11:11:55 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Metabolism and Drug Interactions: </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>C84DD53D-5B64-47C5-92EE-E2D0E78BD754</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A361190A-A611-4162-AA47-4014AAEBA0B2">
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdOn>2014-07-13 11:12:23 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7E52164F-6FEF-4A1A-A55B-01314BCEB19B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:19172135-E2AA-4088-BCFD-164180C591A3</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEA0DB9F-24A6-4283-B426-FDECA24BE603">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-07-13 11:12:34 -0400</pav:createdOn>
    <ao:prefix> plus </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EEA0DB9F-24A6-4283-B426-FDECA24BE603"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>EEA0DB9F-24A6-4283-B426-FDECA24BE603</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F94384BA-7A08-4E0D-A89C-A73959BAA203">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:2D596385-5BFD-4D31-8E3A-AF1CD1B646BB</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:55C36B4E-CDCE-4B16-94D5-178014A48A7F"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 11:09:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CAB91F57-2F70-4DDB-9BF8-A50167C8BBCE">
    <pav:createdOn>2014-07-13 12:40:40 -0400</pav:createdOn>
    <domeo:uuid>CAB91F57-2F70-4DDB-9BF8-A50167C8BBCE</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CAB91F57-2F70-4DDB-9BF8-A50167C8BBCE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A810EBBA-9C6C-4A0D-9FD2-AFA2874096F5">
    <ao:exact>norethindrone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and </ao:prefix>
    <domeo:uuid>A810EBBA-9C6C-4A0D-9FD2-AFA2874096F5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A810EBBA-9C6C-4A0D-9FD2-AFA2874096F5"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 12:38:23 -0400</pav:createdOn>
    <ao:suffix> compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in t</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E529663E-F098-4A61-A526-168945DFC957">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE1A087B-7CF8-4549-978E-17FEC965A2FF">
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:42:27 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:B266BF7D-76BD-461F-B348-21B59090D7D3</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:A1560B5F-D6E1-47EC-A088-C0C90A150994"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CA0AE675-8281-46D4-AD74-54B4F3150E52">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2CF891F7-2E96-4382-8EDB-5C061E8E1AFA">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7AACEF8D-2EBC-4F0B-94B2-190650E562F6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F1DD8EF-72E2-425B-B98B-233F1591A13F"/>
    <pav:lastSavedOn>2014-07-07 09:44:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:08C0C288-6DF4-43E6-A618-71A8BB9563C3</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:EEA8C6CB-C786-4D23-908D-E615652DD4F2</pav:lineageUri>
    <pav:createdOn>2014-07-07 09:42:06 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:FCA2BF23-0BE3-409F-9177-761812F96097</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C901133-925A-4BA8-947F-0FE9FB6D60DB">
    <domeo:uuid>5C901133-925A-4BA8-947F-0FE9FB6D60DB</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>ethinyl estradiol</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C901133-925A-4BA8-947F-0FE9FB6D60DB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 12:38:04 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nad3798ec80d04bc6967c5c08004882ab">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB01A892-8D67-4A38-8CA4-2D230875A1F6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:17:12 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <ao:suffix> and 9-hydroxyrisperidone combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours.</ao:suffix>
    <ao:prefix> was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinetics of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB01A892-8D67-4A38-8CA4-2D230875A1F6"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CB01A892-8D67-4A38-8CA4-2D230875A1F6</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E73E8FF7-7FA2-47F3-B0B1-14D1640DDBF7">
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 11:10:54 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:469138F3-F092-499E-AF0F-B2CB920DF026</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:789A1E1D-CA44-4410-B654-F6392AB94EDC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:789A1E1D-CA44-4410-B654-F6392AB94EDC">
    <domeo:uuid>789A1E1D-CA44-4410-B654-F6392AB94EDC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:789A1E1D-CA44-4410-B654-F6392AB94EDC"/>
    <pav:createdOn>2014-07-13 11:10:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic con</ao:suffix>
    <ao:exact>albumin</ao:exact>
    <ao:prefix> is bound to </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A95EA236-59E2-47FB-878A-81116D82930F">
    <ao:prefix> are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of </ao:prefix>
    <ao:suffix> occurred at about 1 hour. Peak concentrations of 9-hydroxyrisperidone occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and w</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A95EA236-59E2-47FB-878A-81116D82930F"/>
    <pav:createdOn>2014-07-13 11:10:15 -0400</pav:createdOn>
    <domeo:uuid>A95EA236-59E2-47FB-878A-81116D82930F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:00CDF4D6-2271-4B2A-9836-98BD00E7E952">
    <ao:exact>ethinyl estradiol</ao:exact>
    <ao:prefix> 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <domeo:uuid>00CDF4D6-2271-4B2A-9836-98BD00E7E952</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:00CDF4D6-2271-4B2A-9836-98BD00E7E952"/>
    <pav:createdOn>2014-07-13 12:42:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> or </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:10BB95F9-1856-4D70-9976-235CE8AD3D39">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 11:36:13 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:131835A3-C655-4F91-97D4-52CAFF7B7CCA</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:76FD4BB5-DE2F-4FCA-B93D-302185B1A381</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:22ED7220-C6F6-43C5-9DF9-89F62F0F8E27</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:58C251EE-2C78-4764-B2EC-4DBA240A5FD1</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:2D04CBBE-379A-4D9F-BDD4-AA3663CD4669"/>
    <ao:body rdf:nodeID="N809a6eea882c41a5aa4f408471a4f496"/>
    <pav:previousVersion>urn:domeoserver:annotationset:8F3CF3D9-AADE-4A86-BD42-2924B3D6A406</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N395247a7e1ed4e71aab5f30ea6f2d063"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:36:14 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8070f72a9470415a816914e8fda9eb15">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB311B8D-11CB-4B44-BDC1-9641D482BE0D">
    <ao:prefix> and α1-acid glycoprotein. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>AB311B8D-11CB-4B44-BDC1-9641D482BE0D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB311B8D-11CB-4B44-BDC1-9641D482BE0D"/>
    <pav:createdOn>2014-07-13 11:18:02 -0400</pav:createdOn>
    <ao:exact>Risperidone</ao:exact>
    <ao:suffix> doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0CE6C620-40B4-4E55-8185-8A319ECD6D71">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:553A6608-733A-477E-BDCB-F0D16F1054E3"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE4A37C3-330E-406A-8B07-E596729011D4">
    <pav:createdOn>2014-07-13 12:46:33 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:8631DCC5-B27D-47B4-B621-CA41E8FF2E7A</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:ECB23C3B-E835-480F-B541-EB5CBBAB2855"/>
    <pav:lastSavedOn>2014-07-13 12:48:45 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:EC9B90D7-F9B5-4E51-94E2-878FAA06F611</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/07C054FB-6445-437D-B6D9-477EF937289F">
    <rdfs:label>erythromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0ECD29D-DAB1-4D63-85F1-1839E3B04BF6">
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydro</ao:suffix>
    <pav:createdOn>2014-07-13 11:11:19 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E0ECD29D-DAB1-4D63-85F1-1839E3B04BF6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> nor </ao:prefix>
    <domeo:uuid>E0ECD29D-DAB1-4D63-85F1-1839E3B04BF6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9f3a4e17e09b48f1b0922df27a510bef">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AFDFD2C0-7545-4E19-ABAA-7E48CFD82223">
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1593c06e90314edea19be995cd63ccee">
    <domeo:sets rdf:resource="urn:pddi:uuid:76B24ED1-159D-4411-BD4C-8033557FAD2B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8EAC93E7-05D8-439B-86B4-7B47CB07E8D8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:12670ED8-C472-4DF9-A553-567C7F4720E9</pav:lineageUri>
    <pav:createdOn>2014-07-13 11:17:15 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:70B9E8E9-06ED-4420-9CDE-4E0F36F57CC9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C5023B49-22AF-4880-9F9A-B1FCB16EAE71">
    <domeo:uuid>C5023B49-22AF-4880-9F9A-B1FCB16EAE71</domeo:uuid>
    <ao:prefix>Oral contraceptives were administered as a single dose both before and after the oral administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C5023B49-22AF-4880-9F9A-B1FCB16EAE71"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 12:42:01 -0400</pav:createdOn>
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix> 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in ethinyl estradiol or </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/60257C53-72AE-476E-AFC6-21B1AA00F626">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:159DCA30-3727-4241-9440-301E40381956">
    <ao:suffix> (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 11:11:31 -0400</pav:createdOn>
    <ao:prefix> (100 mcg/mL), </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>159DCA30-3727-4241-9440-301E40381956</domeo:uuid>
    <ao:exact>warfarin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:159DCA30-3727-4241-9440-301E40381956"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF873305-5222-4D37-9C71-925D3C390B7A">
    <pav:createdOn>2014-07-13 11:09:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CF873305-5222-4D37-9C71-925D3C390B7A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CF873305-5222-4D37-9C71-925D3C390B7A"/>
    <ao:prefix>, its major metabolite, 9-</ao:prefix>
    <ao:suffix>, and </ao:suffix>
    <ao:exact>hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6864EB3-C97B-4F46-976B-E976F8C03348">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>F6864EB3-C97B-4F46-976B-E976F8C03348</domeo:uuid>
    <pav:createdOn>2014-07-13 11:15:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F6864EB3-C97B-4F46-976B-E976F8C03348"/>
    <ao:prefix>) with </ao:prefix>
    <ao:exact>risperidone</ao:exact>
    <ao:suffix> may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak b</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE972F8D-C1AD-46A9-B34B-1D883FDAF1EC">
    <domeo:uuid></domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>to patients with systemic hypertension, the mean change from baseline in systolic and diastolic blood pressures was a decrease of 9.4 mmHg and 9.1 mmHg, respectively.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>CE972F8D-C1AD-46A9-B34B-1D883FDAF1EC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:40:14 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CE972F8D-C1AD-46A9-B34B-1D883FDAF1EC"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A36E11B0-6726-4AD1-ACC7-4E8E59A350EB">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>levonorgestrel</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6373</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92436D94-1FB4-49B2-B20D-385CA961A940">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:1E6C968E-32AF-45A2-96F3-10B3A640C99F"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812eda990003</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 11:13:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:19D86C58-A255-44F5-87D8-8E8795312D29</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 11:32:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:71191E51-53CB-4FDE-88D0-33C6818E2232</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8FE58707-AFDD-4F32-9EA8-03EC3BF4D67B">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sildenafil</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5d289d8aebe34c1fb3f0e0c245c38156">
    <domeo:sets rdf:resource="urn:pddi:uuid:E8B9127A-D513-4699-BEA0-07E095BADF5D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E6C968E-32AF-45A2-96F3-10B3A640C99F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>Risperidone</ao:exact>
    <domeo:uuid>1E6C968E-32AF-45A2-96F3-10B3A640C99F</domeo:uuid>
    <pav:createdOn>2014-07-13 11:13:53 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1E6C968E-32AF-45A2-96F3-10B3A640C99F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> could be subject to two kinds of drug-drug interactions. First, inhibitors of CYP 2D6 interfere with conversion of risperidone to 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F049BA4A-8DAF-49C1-ABA1-6E76A2F6DA6B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A36E11B0-6726-4AD1-ACC7-4E8E59A350EB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1FCFC8E7-95A0-4188-9582-891391C2CFE6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nce581b8f5faf488590b098cd49a7605c">
    <domeo:sets rdf:resource="urn:pddi:uuid:FC76D7A1-BCF3-4AF0-92CC-E5D2F09F6BD7"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N511a9ab417244d2eba8f728ae193e85e">
    <domeo:sets rdf:resource="urn:pddi:uuid:8186AE14-85DE-4E1A-B5F4-BC58233DC47B"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B7CB635F-4EBF-434B-9159-71DC46A33588">
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C2471146-B114-47FF-BB78-F58B6158FB99">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DC200567-4E8F-495B-9D13-A2A04A7A47EC"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30818391-5098-4A86-BF01-5AB0C0597335">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30818391-5098-4A86-BF01-5AB0C0597335"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> displaces each other from plasma binding sites. High therapeutic concentrations of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>s</ao:exact>
    <pav:createdOn>2014-07-13 11:11:27 -0400</pav:createdOn>
    <domeo:uuid>30818391-5098-4A86-BF01-5AB0C0597335</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55C36B4E-CDCE-4B16-94D5-178014A48A7F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>55C36B4E-CDCE-4B16-94D5-178014A48A7F</domeo:uuid>
    <ao:prefix>Plasma concentrations of </ao:prefix>
    <pav:createdOn>2014-07-13 11:09:28 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:55C36B4E-CDCE-4B16-94D5-178014A48A7F"/>
    <ao:exact>risperidone</ao:exact>
    <ao:suffix>, its major metabolite, 9-hydroxyrisperidone, and risperidone plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma conce</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BA258499-09C3-45B8-8CA4-4B430E2DB5EB">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E529663E-F098-4A61-A526-168945DFC957"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/60257C53-72AE-476E-AFC6-21B1AA00F626"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DCA0957A-745E-4232-BE6B-45104AD0FFCD">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/021311B6-82A4-4AA1-97CE-B7A322F4EE50"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CA0AE675-8281-46D4-AD74-54B4F3150E52"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0EE858B-D738-4E79-B01E-E50A3141586B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>quinidine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A0EE858B-D738-4E79-B01E-E50A3141586B</domeo:uuid>
    <ao:suffix>, giving essentially all recipients a </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A0EE858B-D738-4E79-B01E-E50A3141586B"/>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. This occurs with </ao:prefix>
    <pav:createdOn>2014-07-13 11:15:01 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N167cd30c82bb481c9f33961fa16ce5a6">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3726534af4fd45c583ba1fd3f0a5be24">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Neb5627b9feaf4d479103a379d17a0fb7">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb49daa32b1b24910b2b0b9300c519f04">
    <domeo:sets rdf:resource="urn:pddi:uuid:114406CD-55D0-459D-A4F0-CEDB09E201C6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfe9f8439115a43fdb3769fde786e7730">
    <domeo:sets rdf:resource="urn:pddi:uuid:C2471146-B114-47FF-BB78-F58B6158FB99"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd8671dcd5b9c47b59c30819a64ee9dbb">
    <domeo:sets rdf:resource="urn:pddi:uuid:D7F3CF4B-F577-4BF7-B88B-B5D04D01A04A"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E4072F00-AC18-479B-BBF5-FE87E12CA45B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E5FE9EFB-83B0-4935-97F9-6C46842B3260">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/58FED583-F7D0-4B0E-913A-6142C90539F0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/07C054FB-6445-437D-B6D9-477EF937289F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Neb2778f97e154b1190ba1db6604ff6fa">
    <domeo:sets rdf:resource="urn:pddi:uuid:A3DCC3AB-4469-4227-B682-6E7F65CD2A7A"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne6d6f44b868b4d9fbfa16a26d57ec715">
    <domeo:sets rdf:resource="urn:pddi:uuid:799D7550-4333-4600-A69B-DE23093443A4"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N809a6eea882c41a5aa4f408471a4f496">
    <domeo:sets rdf:resource="urn:pddi:uuid:7561E693-ED7F-438D-97B3-6718EA0765EF"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfaf4dffc8e564e0baefb87b715f8f7a8">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
</rdf:RDF>
